[
    {
        "pmid": "40818237",
        "title": "Risk communication during treatment decision-making conversations with older people with advanced kidney disease.",
        "abstract": "older people advanced kidney disease medically ineligible transplant hence treatment available dialysis conservative kidney management CKM Previous research indicates information patient receive clinicians dialysis often prioritised CKM However evidence older people health issues dialysis always beneficial aim investigate whether risk benefit discussed relation option consultations convey CKM valid option Outpatient consultation recorded across four UK renal unit purposively selected variability CKM rate amongst patient age 65 Chronic Kidney Disease data British English total 30 conversation identified concerned decision dialysis CKM 22 led doctor 8 led nurses included 20 conversation option listed undecided patients eight prior decision revisited two recommendation made dialysis Conversations analysed using conversation analysis found CKM treated valid option patient risks burden limited benefit dialysis framed significant term quality andor length life found following aspect clinician communication enabled patient respond way treated CKM valid treatment option 1 talking impact dialysis persons quality life 2 conveying uncertainty regarding potential benefit dialysis length life 3 conveying risk personally relevant patients circumstances Findings demonstrate clinician convey information patient risk dialysis advanced kidney disease enable patient recognise consider CKM valid option",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818237/",
        "source_type": "Global"
    },
    {
        "pmid": "40817567",
        "title": "The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference.",
        "abstract": "Laboratory investigation important clinical management study chronic kidney diseasemineral bone disorder CKDMBD including CKDassociated osteoporosis Parathyroid hormone PTH major hormone regulation bone calcium balance significantly affected advanced CKD Knowledge PTH concentration important assessment osteoporosis including CKDassociated osteoporosis however measurement PTH laboratory bedevilled interference intermethod difference compounded lack standardisation commonly used immunoassays Vitamin important bone health deficiency contributes development osteoporosis Vitamin metabolism impaired advanced CKD augmenting effect deficiency bone health Lack consensus optimal serum 25hydroxyvitamin 25OHD concentration bone health including various CKD stages compounded lack analytical specificity immunoassays Liquid chromatography tandem mass spectrometry LCMSMS assay would help overcome issues Ionised calcium measurement recommended assessment serum calcium especially CKD Fibroblast growth factor 23 FGF23 important homeostasis phosphate accumulates CKD though marker yet utilized clinical context Calculated maximal tubular reabsorption phosphate normalized glomerular filtration rate TmPGFR may help assessment phosphate homeostasis Bone specific alkaline phosphatase BALP tartrateresistant acid phosphatase isoform 5b TRACP5b reference marker bone formation resorption CKDassociated osteoporosis shown reflect bone turnover histomorphometry patient advanced CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817567/",
        "source_type": "Global"
    },
    {
        "pmid": "40815832",
        "title": "Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective Study.",
        "abstract": "Psoriasis chronic inflammatory disease associated multiple comorbidities including metabolic syndrome cardiovascular disease Although specific dietary interventions intermittent fasting caloric restriction shown ameliorate inflammation promote weight loss effect intervention independent weight loss remains unclear Timerestricted eating TRE type intermittent fasting limit daily eating window fixed number hours Recent study suggest TRE may improve immune function individual metabolic syndrome cardiovascular risk factors crucial advantage TRE investigated dietary restriction strategy reported high adherence rate making feasible intervention longterm use Therefore exploring effect TRE metabolic immunological parameter psoriasis warranted study designed evaluate effect shortterm isocaloric TRE independent weight loss immune cell function serum metabolite profile volunteer mildtomoderate psoriasis compared healthy individuals casecontrol prospective study performed 10 healthy male participant 10 age BMI sexmatched individual mildtomoderate psoriasis individual psoriasis stable disease treated topical therapy without exposure immunomodulatory biologics study conducted National Institutes Health Clinical Center Immune profiles glucose handling energy expenditure participants weight assessed baseline 3 day TRE following daily 6hour eating window 18hour fast trial commenced June 2021 completed February 2023 total 20 participant enrolled10 mildtomoderate psoriasis 10 age BMI sexmatched healthy individuals time manuscript submission data processing ongoing Multiomic datasets including gene expression surface intracellular protein levels metabolite profiles generated peripheral blood mononuclear cells CD4supsupenriched Tcells serum samples integrated bioinformatics analysis reported data analysis completed clinical protocol designed characterize effect short term 3day TRE psoriasis independent weight loss comparing immune cell regulatory response healthy individual psoriasis specifically aim map molecular pathway activated TRE assess affect immune cell composition activation metabolism Additionally component metabolic response isocaloric TRE explored Insights dietary intervention impact metabolism immune system enhance understanding pathogenesis psoriasis may reveal new therapeutic avenue managing inflammatory condition ClinicalTrialsgov NCT04728165 httpsclinicaltrialsgovstudyNCT04728165",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815832/",
        "source_type": "Global"
    },
    {
        "pmid": "40814749",
        "title": "Microfluidic Chip with Integrated Whole Blood Separation for Simultaneous Accurate Quantification of Multiple Chronic Kidney Disease Markers and Long-Term Monitoring.",
        "abstract": "Chronic kidney disease CKD become public health burden high mortality rate trend toward youthfulness imperative develop home monitoring system early diagnosis longterm monitoring CKD serum biomarkers However due limitation conventional centrifugation preprocessing whole blood samples realtime detection platform cannot fully meet requirement obtaining quantitative result directly whole blood Herein novel smartphoneassisted microfluidic chip integration whole blood separation pointofcare testing POCT system proposed achieve accurate quantification CKD biomarkers uric acid UA creatinine CR albumin Alb based 30 μL whole blood fingertip blood whole blood separation module allows rapid separation plasma whole blood sample vertical flow smartphone App automated image recognition processing developed applied athome routine healthcare detection limit UA CR Alb 01127 mmolL 02978 μmolL 07696 mgmL respectively meeting clinical requirements Additionally quantitative performance 83 clinical whole blood sample showed high consistency clinical analyzer Beckman AU 5400 automatic biochemical analyzer system simple operate userfriendly providing accurate rapid costeffective reliable detection method early screening realtime monitoring CKD hold significant potential enhancing home selfmanagement CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814749/",
        "source_type": "Global"
    },
    {
        "pmid": "40814743",
        "title": "Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years.",
        "abstract": "dual burden diabetes kidney disease pose growing public health challenge aging populations yet longitudinal trend modifiable determinant China remain understudied study aim track trend prevalence comorbidity diabetes kidney disease Chinese middleaged older adult 10year period 20112020 identify social determinant lifestyle factor associated comorbidity study utilized data five wave China Health Retirement Longitudinal Study CHARLS Temporal trend geographical distribution comorbidity diabetes kidney disease analyzed across survey years disaggregated sex residence geographical region Cox proportional hazard regression model employed explore association SDOH burden lifestyle factors risk comorbidity prevalence diabetes kidney disease comorbidity exhibited clear upward trend among Chinese adult aged ≥ 45 years increasing 060 2011 310 2020 Geographical analysis revealed significant regional disparities Northeast China highest prevalence throughout decade 476 2020 High SDOH burden associated increased risk comorbidity HR  124 95 CI  101152 Conversely maintaining good HR  038 95 CI  027054 moderate HR  074 95 CI  059091 lifestyle associated reduced risk rising prevalence significant regional disparity diabetes kidney disease comorbidity underscore urgent need targeted public health intervention China",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814743/",
        "source_type": "Global"
    },
    {
        "pmid": "40814623",
        "title": "Economic Evaluation of System-Wide Implementation of Kidney Supportive Care.",
        "abstract": "evaluation explored economic value kidney supportive care KSC patient endstage kidney disease ESKD receiving dialysis conservative management ESKD public health system New South Wales Australia Deidentified patientlevel data extracted linked dataset admitted nonadmitted patient data emergency department episodes death registrations Data 1 July 2015 30 June 2019 compared usual treatment prior statewide KSC implementation 20152016 financial years costbenefit analysis model estimated current economic value KSC 1 July 2015 30 June 2019 projected value 30 June 2030 different scenarios proportion patient ESKD receiving KSC increased 5 2015 2016 ini  443 16 2018 2019 period KSC estimated increase survival 3 21 weeks depending patient characteristics Projections showed continued delivery KSC ESKD treatment modality pattern cost remaining stable would deliver net economic benefit A 109 million avoided cost care return investment ROI 212 adjusted include survival improvement attributable KSC net economic benefit increased A 275 million ROI 535 Economic evaluation statewide KSC service showed survival benefit net economic benefit 4 year implementation Net economic value 10 year estimated A 275 million would increase greater participation patient ESKD suitable KSC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814623/",
        "source_type": "Global"
    },
    {
        "pmid": "40814615",
        "title": "Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.",
        "abstract": "Type 2 diabetes chronic kidney disease CKD preventable treatable silent progressive clinical course call structured assessment timely feedback patient care provider activating decisionmaking Apart CKD patient diabetes complication affecting multiple organs notably cardiovascular system eyes feet International practice guideline recommend annual assessment eyes feet blood urine detect silent complication measure cardiovascularkidneymetabolic CKM risk factor ensure early intervention including treatment multiple target use organprotective drugs report highlight barrier gap implementation practice guideline managing diabetes CKD proposed solution overcome barriers improving practice environment workflow nurse trained perform protocolguided evaluation medical supervision systematic data collection enables physician make timely decisions including drug prescription referral specialist promote collaborative care whereas nurse use personalized data empower patient selfmanagement improve health literacy ongoing data collection form register align payers providers patient delivering datadriven valuebased care creation realworld evidence verify treatment effectiveness identify care gap providing onthejob training accompanied biobank ongoing collection analysis multidimensional data refine diagnosis classification prognosis treatment pursuit precision medicine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814615/",
        "source_type": "Global"
    },
    {
        "pmid": "40814014",
        "title": "Chronic and reactivated dengue infection in an immunocompromised host: insights from a case report.",
        "abstract": "Dengue viral infection transmitted mosquitoes growing global health concern particularly spread put half worlds population risk dengue usually resolve primary infection persistent chronic case occur immunocompromised individuals case study report 43yearold woman lupus nephritis endstage kidney disease experienced symptomatic dengue reactivation nearly three year initial infection Despite low viral loads dengue RNA detectable blood multiple time 32 34 month initial detection Genomic analysis confirmed DENV1 strain persisted suggesting chronic infection rather reinfection patients immunosuppressive treatments including rituximab likely impaired immune response initial infection contributing viral persistence Additionally profound immunosuppressive state time reactivation potentially exacerbated coinfections may triggered virus reemerge case highlight rare clinically relevant possibility chronic dengue infection immunocompromised patients confirmed persistence viral strain nearly three year challenge conventional view dengue strictly acute infection raise concern potential reintroduction reemergence previously circulating strains well detrimental tissue consequence chronic infection virus finding important implication clinical management diagnostic strategies public health surveillance underscore need research better understand mechanism dengue chronicityparticularly involving viral immune evasion host immune dysfunction",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814014/",
        "source_type": "Global"
    },
    {
        "pmid": "40813151",
        "title": "Kidney failure risk equation (KFRE), A risk-based triage for nephrology referrals: A mixed-methods study at pre-implementation phase among healthcare providers.",
        "abstract": "Chronic kidney disease CKD pose significant health challenge globally limited understanding challenge opportunity enhance CKD management perspective healthcare provider HCPs involved direct care patient CKD integrate riskbased triage nephrology referrals namely kidney failure risk equation KFRE explored HCPs perspective facilitator barrier CKD management implementation KFRE used mixed method approach explore HCPs perspective 1 facilitator barrier CKD management 2 perceived benefit challenge implementing KFRE riskbased triage guide nephrology referral Universiti Malaya Medical Centre UMMC Kuala Lumpur Malaysia Interviews audio recorded transcribed verbatim thematically analyzed Quantitatively provider job satisfaction survey performed Overall 111 HCPs completed surveys majority mostly satisfied physical surroundings coworkers supervision received Mixed response expressed amount work equipment provided Interviews conducted among 27 HCPs three main CKD care provider group primary care medicine nephrology endocrinology facilitators barriers theme identified top three barrier CKD management suboptimal patients insights gap practice confidences shortfall healthcare system contrast good interdisciplinary network accessibility specialist resource key facilitators underscored importance human resource empowerment continuous patient education structured interdisciplinary collaboration HCPs perceived riskbased triage using KFRE potentially useful targeted care identified several modifiable barrier facilitator warranting attention improve health outcome people CKD riskbased triage approach using KFRE appears promising facilitating targeted nephrology referral better care resource allocations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813151/",
        "source_type": "Global"
    },
    {
        "pmid": "40812774",
        "title": "Renal Involvement in Chronic Graft-Versus-Host Disease.",
        "abstract": "Graft versus host disease GvHD common complication allogeneic hematopoietic stem cell transplantation HSCT skin eyes mouth liver commonly affected organ chronic GvHD increasing recognition less typical site involvement Emerging evidence suggests kidney may also affected however current data remain limited largely derived small retrospective study case series examined cohort 1441 patient transplanted identified 12 patient 08 presenting nephrotic syndrome renal biopsy consistent membranous nephropathy MN None patient preexisting renal disease patient nephrotic range proteinuria median 66 g24 h range 41178 presentation median time diagnosis glomerular disease 18 year range 0643 years HSCT median time diagnosis nephrotic syndrome 407 day range 951415 days initial diagnosis chronic GvHD Three patient feature renal vein thrombosis presentation patient showed typical pathologic feature MN additional mild microangiopathic feature ultrastructural examination nine tested PLA2R negative patient received immunosuppressive therapy Seven complete response treatment four achieved partial response one respond Herein describe clinical characteristics disease course clinical outcomes None patient developed irreversible renal impairment outlining importance rapid intervention appropriate immunosuppression absence effective biomarkers management suspected renal GvHD presenting proteinuria include renal biopsy identify appropriately classify lesion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812774/",
        "source_type": "Global"
    },
    {
        "pmid": "40812709",
        "title": "Ozone serve as mediator and effect modifier in the temperature-eGFR association: A longitudinal study on health examination cohort.",
        "abstract": "precise role ozone Osub3sub modulating temperatures impact kidney function remains unclear study systematically investigates Osub3subs modification mediation effect association temperature glomerular filtration rate eGFR collected 26244 individual First Affiliated Hospital Jinan University Generalized Linear Mixed Model used analyze mediation interaction effect Osub3sub temperatureeGFR association QuantileBased gComputation model estimated joint effect found eGFR decreased 029 mLmin173 msup2sup 95  CI 032 026 per 1 °C increase temperature 036 mLmin173 msup2sup 95  CI 039 032 per 10 μgmsup3sup Osub3sub increase IQR increase temperature Osub3sub led 325 mLmin173 msup2sup eGFR decline 95  CI 327 323 temperature Osub3sub contributing 6753  3247  respectively significant synergistic effect Osub3sub temperature observed high temperaturehigh Osub3sub HTHO event associated greatest relative risk RR  271 95  CI 236313 low eGFR compared low temperaturelow Osub3sub LTLO events Approximately 2056  total effect partly explained Osub3sub Individuals rapid renal function decline vulnerable temperature Osub3sub associated reduced renal function Osub3sub acting mediator modifier",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812709/",
        "source_type": "Global"
    },
    {
        "pmid": "40812666",
        "title": "Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors - a cross-site multi-cycle audit.",
        "abstract": "Sodiumglucose transport2 inhibitor commonly prescribed management type 2 diabetes mellitus chronic kidney disease heart failure However continuation perioperative setting people diabetes precipitate euglycaemic diabetic ketoacidosis eDKA potentially lifethreatening complication multicycle audit evaluated adherence perioperative guideline regarding preoperative cessation postoperative reinitiation SGLT2 inhibitors Electronic health record consecutive surgical patient type 2 diabetes reviewed sixmonth period Two case eDKA identified Targeted interventionsincluding staff education dissemination guidancewere implemented followed reaudit fourmonth period Documentation perioperative SGLT2 inhibitor cessation improved significantly postintervention however postoperative ketone monitoring remained suboptimal one case eDKA identified Since then capillary blood ketone monitoring introduced clinical areas finding add body evidence perioperative use SGLT2 inhibitors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812666/",
        "source_type": "Global"
    },
    {
        "pmid": "40811628",
        "title": "Chronic kidney disease among HIV-positive Zambian adults with tenofovir-associated nephrotoxicity at University Teaching Hospital (UTH) in Lusaka.",
        "abstract": "Tenofovir disoproxil fumarate TDF nucleotide reverse transcriptase inhibitor NRTI widely used firstline antiretroviral therapy ART Despite efficacy TDF associated nephrotoxicity particularly patient renal impairment background country including Zambia replacing TDFbased regimen Tenofovir Alafenamide TAF study aimed determine association TDFinduced nephrotoxicity three month chronic kidney disease CKD within five year among people living HIV PLWH Zambia retrospective cohort study 182 PLWH conducted Adult Center Infectious Disease Research AIDC Lusaka Zambia incidence CKD factor associated development PLWH initiated TDF evaluated Kidney function trend monitored five years Statistical analysis including MixedEffect model Cox Proportional Hazards Regression model conducted assess relationship early nephrotoxicity longterm CKD total 63 3462 182 file showed patient developed CKD contributing total persontime 910 personyears incidence rate CKD 692 case per 1000 personyears finding indicated significant association TDFassociated nephrotoxicity development CKD within five years mixedeffects model accounted populationlevel trend individual variability ensuring robust results Findings showed removing outlier made model representative significant decline kidney function time Cox regression model identified male sex baseline creatinine substantial risk factor CKD good model fit discriminatory power Given findings recommended regular monitoring early intervention strategy reinforced patients Furthermore continuous evaluation kidney function time crucial effectively manage mitigate risk associated CKD PLWH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811628/",
        "source_type": "Global"
    },
    {
        "pmid": "40811028",
        "title": "Association of Volume Status Assessed by Bioimpedance with Blood Pressure in CKD.",
        "abstract": "Hypertension common among patient CKD risk factor cardiovascular event mortality Though hypervolemia contributor hypertension association blood pressure biomarkers volume among patient CKD unclear Using data 5384 patient Chronic Renal Insufficiency Cohort CRIC fit linear regression model examine association vector length bioimpedance proxy volume systolic diastolic blood pressure BP employed categorical analysis given evidence nonlinear associations also assessed whether change vector length two year baseline associated change BP mean age 59 ±11 years 44 female 43 Black mean systolic BP eGFR 129 ±21 mmHg 48 ±16 mLmin173m2 respectively association vector length systolic BP nonlinear lowest quartile vector length a proxy hypervolemia associated 32 mmHg 95CI 11 53 higher systolic BP compared third quartile Compared third quartile two years lowest quartile change vector length a proxy volume expansion associated increase systolic BP 30 mmHg 95CI 10 51 Diastolic BP associated vector length Shorter shortening vector length independently associated higher increasing systolic BP respectively Whether bioimpedanceguided optimization volume status could improve BP management among patient CKD requires investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811028/",
        "source_type": "Global"
    },
    {
        "pmid": "40810375",
        "title": "Safety of Hemorrhoid Procedures in Patients who are Immunocompromised: The Mayo Clinic Experience.",
        "abstract": "Hemorrhoidal disease immunosuppression prevalent Management hemorrhoidal disease patient population challenging society recommend conservative management due presumed risk morbid complications including sepsis impaired healing Data risk officebased operative procedure immunocompromised patient scant evaluate postoperative outcome officebased procedure operative intervention hemorrhoidal disease immunocompromised patients Retrospective chart review Singlecenter tertiary referral center Adult patient hemorrhoidal disease primarily medicationinduced immunosuppression undergoing officebased procedure operative intervention hemorrhoidal disease immunosuppression Mayo Clinic Rochester 2010 2023 primary outcome development infectious complication wound complications Fiftyfive immunocompromised patients median age 60 underwent total 68 hemorrhoidal procedure study time frame patient immunosuppression induced medication except one patient bone marrow failure syndrome common reason immunosuppression rheumatoid arthritis followed prior kidney transplant common medication chronic corticosteroid methotrexate third patient each 68 total interventions hemorrhoidectomy 32 excision thrombosed hemorrhoid 26 two common operation performed Sixteen adverse event reported 14 25 patients Three case postoperative cellulitis documented thrombosed external hemorrhoid excision hemorrhoidopexy Whitehead hemorrhoidectomy postoperative intravenous antibiotic administered case pelvic sepsis documented retrospective nature study heterogeneity study population data suggest officebased surgical procedure safe feasible patient immunosuppression See Video Abstract",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810375/",
        "source_type": "Global"
    },
    {
        "pmid": "40810067",
        "title": "Predictive value of ferritin heavy chains in the development of coronary artery calcification in patients on maintenance hemodialysis: a prospective cohort study.",
        "abstract": "Vascular calcification VC wellestablished risk factor cardiovascular disease CVD mortality patient maintenance hemodialysis MHD patient frequently present hyperphosphatemia well disorder iron metabolism study aim explore role ferritin heavy chain FTH development progression coronary artery calcification CAC patient MHD assess predictive value Using bioinformatics approach analyzed datasets related VC prospective study evaluated Coronary Artery Calcification Score CACS alongside clinical markers including serum FTH serum ferritin transferrin saturation TSAT patient MHD baseline 1year followup Fth1 identified differentially expressed gene significantly upregulated aorta ApoEsupsup mouse atherosclerotic calcification model chronic kidney disease CKD mouse medial calcification model Among patient MHD 8571 exhibited CAC 4909 showing progression Patients CAC tended older higher body mass index BMI Notably serum FTH phosphorus P level significantly elevated progressive CAC Elevated serum FTH high serum P independent risk factor CAC progression showed predictive value Elevated serum FTH high serum phosphorus clinically significant predictor VC progression patient MHD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810067/",
        "source_type": "Global"
    },
    {
        "pmid": "40809416",
        "title": "Advancements in the non-invasive diagnosis of renal fibrosis.",
        "abstract": "Renal fibrosis central pathological pathway various primary secondary kidney disease progress endstage renal disease characterized excessive extracellular matrix deposition destruction native renal parenchyma ultimately leading irreversible loss nephrons Currently percutaneous renal biopsy histopathological evaluation remains diagnostic gold standard renal fibrosis allowing semiquantitative scoring renal interstitial fibrosis glomerulosclerosis eg Banff grading However invasive procedure carry risk bleeding limited sampling error interobserver variability making impractical dynamic disease monitoring recent years significant advance made noninvasive diagnostic techniques include 1 blood urine biomarkers marker ECM metabolism inflammatory factors tubular injury markers extracellular vesicles 2 imaging modality including novel ultrasound techniques shear wave elastography functional magnetic resonance imaging MRI method diffusionweighted imaging blood oxygen leveldependent MRI magnetic resonance elastography positron emission tomographycomputed tomography using radiotracers targeting fibrosisassociated molecule sup68supGaFAPI review systematically summarizes latest evidence biomarkers advanced imaging modalities emphasis diagnostic performance sensitivityspecificity utility dynamic monitoring bottleneck clinical translation aim develop multimodal noninvasive assessment system enable earlier fibrosis detection stratified disease management precise intervention targeting fibrogenic pathways ultimately improving renal disease outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809416/",
        "source_type": "Global"
    },
    {
        "pmid": "40809316",
        "title": "The anti-aging potential of antihypertensive peptides of <i>Pariset</i>, a dataset of algal peptides.",
        "abstract": "Cellular senescence drive aging disease promoting inflammation tissue dysfunction kidneys highly susceptible aging worsen hypertension increasing chronic disease risk Managing blood pressure angiotensinconverting enzyme ACE inhibitor natural bioactive peptide help maintain kidney health study explores kidneyassociated aging network algal peptide renoprotective antiaging effects Senescenceassociated gene Human Ageing Genomic Resources HAGR used construct analyze proteinprotein interaction PPI network refining kidneyrelated subset ACE angiotensin II Receptor Type 1 AGTR1 angiotensin II Receptor Type 2 AGTR2 Algal antihypertensive peptide filtered laboratory dataset algal peptides iPariseti assessed allergenicity antigenicity toxicity antiaging potential via sequence similarity searches Selected peptide prepared molecular docking tested kidneyaging targets visualized senescenceassociated PPI network revealed key agingrelated proteinsIL1R CD4 FN1 STAT3 CD45 APOE CD44 ITGAM CD8A CD68 CDH1 ACE AGTR1 AGTR2linked inflammation immunity fibrosis Screening identified 54 antihypertensive peptides among seven predicted nonallergenic nonantigenic peptides six exhibited antiaging properties KTFPY others exhibited strong binding ACE kidneyaging proteins suggesting therapeutic benefits senescenceassociated PPI network reveals potentially important agingrelated protein affecting kidney health Algal peptides particularly KTFPY VYRT PGDTY PVAFN MTFF exhibit strong ACE binding suggesting potential antihypertensive antiaging benefits CD68 expressed reliable binding affinity smallmolecule ACE inhibitors indicated repurposing potential drug agingassociated conditions computational result highlight potential peptidebased therapy addressing agerelated kidney dysfunction warrant experimental investigations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809316/",
        "source_type": "Global"
    },
    {
        "pmid": "40808960",
        "title": "Risk factor analysis and outcomes of heart transplant recipients infected by COVID-19.",
        "abstract": "study aim evaluate prevalence clinical characteristics severity mortality outcome COVID19 infection heart transplant recipients focusing risk factor severe disease retrospective observational study conducted adult heart transplant patient HTxs Fuwai Hospital December 1 2022 February 28 2023 followup May 30 2024 Clinical data collected via telephone survey medical records Logistic regression analysis conducted explore risk factor severe disease total 728 916 HTxs infected COVID19 7948 vaccination rate 2795 infected cases 5618 mild 1882 moderate 1926 severe 577 critical Severe disease occurred 2500 mortality rate 454 Logistic regression analysis revealed age OR 1048 95 CI 10311066 P0001 history diabetes OR 1829 95 CI 12212740 P0005 Chronic kidney disease stage≥3 OR 2557 95 CI 16503963 P0001 immunosuppressive regimen including sirolimus OR 1639 95 CI 11452348 P0007 independent risk factor severe infection age OR 1102 95 CI 10531154 P0001 Chronic kidney disease stage≥3 OR 6342 95 CI 298013499 P0001 independent risk factor postinfection mortality COVID19 vaccination OR 0169 95 CI 00390733 P0018 found protective factor postinfection mortality COVID19 vaccination recommended HTxs reduce severe outcome mortality Sirolimus use independently associated severe infection highlighting need careful management immunosuppression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808960/",
        "source_type": "Global"
    },
    {
        "pmid": "40808229",
        "title": "Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease.",
        "abstract": "Cardiovascular disease CVD chronic kidney disease CKD major global health concerns CKD significantly amplifying cardiovascular mortality Statins widely used manage hyperlipidemia recognized lipidlowering property additional benefits including antiinflammatory antioxidant plaquestabilizing effects review explores multifaceted role statin cardiovascular renal protection particularly among CKD patients narrative review synthesizes evidence clinical study assessing cardiovascular renal outcome statin use patient CKD examines effect statin across various clinical scenarios demographics comorbidities focus impact cardiovascular events renal function Statins significantly reduce allcause mortality major adverse cardiovascular event patient mild moderate CKD evidence supporting efficacy across diverse populations Trials JUPITER Heart Protection Study highlight cardiovascular benefit potential stabilize kidney function surgical settings statin show promise mitigating acute kidney injury inflammatory pathway modulation However impact renal outcomes proteinuria albuminuria glomerular filtration rate inconsistent Highdose statins especially advanced CKD may carry risk including hematuria rhabdomyolysis particularly improper dosing drug interactions Safety depends statin type dose renal function Additionally statin reduce risk contrastinduced nephropathy slow CKD progression select populations though variability study design limit generalizability Statins provide substantial cardiovascular benefit CKD patients renal effect remain uncertain Future research aim optimize treatment strategies including personalized regimens balance cardiovascular protection renal safety effectively",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808229/",
        "source_type": "Global"
    },
    {
        "pmid": "40807073",
        "title": "Incidence and Predictive Factors of Acute Kidney Injury After Major Hepatectomy: Implications for Patient Management in Era of Enhanced Recovery After Surgery (ERAS) Protocols.",
        "abstract": "bBackgroundb Acute kidney injury AKI frequently occurs following major liver resection adversely affecting short longterm outcomes study aimed determine incidence AKI posthepatectomy identify relevant pre intraoperative risk factors secondary objective develop predictive score postoperative AKI assess association AKI chronic kidney disease CKD 1year mortality bMethodsb retrospective study cancer referral center Marseille France 2018 2022 bResultsb Among 169 patients 55 325 experienced AKI Multivariate analysis revealed several independent risk factor postoperative AKI including age body mass index use angiotensinconverting enzyme inhibitorsangiotensin receptor blockers time liver resection intraoperative shock bile duct reconstruction Neoadjuvant chemotherapy protective AKIMEBO score developed threshold ≥156 demonstrating sensitivity 895 specificity 764 positive predictive value 618 negative predictive value 944 AKI associated increased postoperative morbidity oneyear mortality following major hepatectomy bConclusionb AKI common complication posthepatectomy Factors time liver resection intraoperative shock management present potential clinical intervention points AKIMEBO score provide valuable tool postoperative risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807073/",
        "source_type": "Global"
    },
    {
        "pmid": "40806393",
        "title": "Assessment of Eotaxin Concentration in Children with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD progressive condition still lead significant morbidity mortality among patient ages proper management focused slowing disease sequelae well establishing early diagnosis treatment complications Eotaxin potent selective eosinophil chemoattractant reported impact various kidney diseases Nevertheless data regarding potential correlation eotaxin CKD pediatric population still scarce study aim assess concentration eotaxin child CKD evaluate potential correlation selected biochemical marker disease occurrence serum urine eotaxin concentration markedly higher child CKD compared healthy controls Moreover Receiver Operating Characteristic ROC curve shown serum eotaxin urine eotaxin level demonstrated high sensitivity high specificity allocation patient study control groups author advanced thesis eotaxin might serve marker CKD occurrence pediatric population research design innovative since analyzed literature yet However study required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806393/",
        "source_type": "Global"
    },
    {
        "pmid": "40804428",
        "title": "Patient characteristics and adverse effects of allogeneic blood transfusion following lower extremity joint replacement in rheumatoid arthritis: a nationwide inpatient sample database study.",
        "abstract": "Allogeneic blood transfusion common therapeutic intervention patient rheumatoid arthritis RA undergoing lower extremity joint replacement LEJR Despite potential adverse outcome associated blood transfusion risk related procedure RA patient remain underexplored particularly within framework largescale national dataset study analyzed data National Inpatient Sample NIS database 2010 2019 identifying 66674 patient diagnosed RA underwent LEJR case subsequently divided two group based whether received blood transfusion Univariate multivariate logistic regression analysis conducted patient demographics prevalence comorbidities hospitallevel characteristics total financial charges insurance coverage inhospital mortality rates cumulative blood transfusion rate among RA patient undergoing LEJR 109 showing declining trend study period from 2379 2010 367 2019 Several factor associated increased likelihood receiving blood transfusion including advanced age ≥ 65 years female sex deficiency anemia chronic blood loss anemia weight loss coagulopathy fluid electrolyte imbalances neurological disorders pulmonary circulatory disturbances congestive heart failure chronic kidney disease uncomplicated diabetes Moreover patient received blood transfusion demonstrated higher risk specific complications including wound infection acute myocardial infarction pneumonia acute kidney injury urinary tract infection postoperative delirium deep vein thrombosis lower limb nerve injury sepsis respiratory failure Thorough preoperative assessment essential identifying RA patient likely receive blood transfusion subjected adverse outcomes Proactive intervention perioperative period coupled implementation comprehensive blood management strategy optimize blood transfusion RA patient LEJR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804428/",
        "source_type": "Global"
    },
    {
        "pmid": "40804029",
        "title": "Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study.",
        "abstract": "Appropriate interpretation kidney function essential clinical therapeutic management heart failure HF evaluated prognostic accuracy 6 glomerular filtration rate estimation eGFR formula HF patient reduced ejection fraction HFrEF impact Metabolic Exercise test data combined Cardiac Kidney Indexes MECKI score prognostic accuracy retrospectively analyzed 6933 patient enrolled MECKI score database GFR estimated using Modification Diet Renal Disease MDRD MRDR modified MDRDm CockcroftGault CG CG modified CGm Chronic Kidney Disease Epidemiology Collaboration CKDEPI European Kidney Function Consortium EKFC Survival assessed composite cardiovascular death left ventricular assist device implantation urgent heart transplantation 2 years GFR estimation demonstrated similar moderate prognostic capacity area curve AUC predicting survival ranging 06271 EKFC 0635 MDRD cardiovascular death AUC value ranged 0668 0677 prevalence severe CKD defined eGFR 30 mlmin173 m² ranged 32 MDRD 45 EKFC included MECKI score 6 formula showed MECKI AUC prognosis ranging 07841 07883 EKFC CKDEPI showing best performance GFR estimation play role HFrEF prognosis without difference among 6 frequently used formulas Furthermore using eGFR calculated 6 different formula MECKI score significantly alter strong prognostic power highlighting MECKI reliability risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804029/",
        "source_type": "Global"
    },
    {
        "pmid": "40803979",
        "title": "Impact of medication therapy management on medication adherence and health-related quality of life among non-dialysis chronic kidney disease patients.",
        "abstract": "Chronic kidney disease CKD progressive disease often associated poor medication adherence reduced health related quality life HRQoL Medication therapy management MTM range service provided patient shown enhance medication adherence HRQoL yet impact nondialysis CKD patient remains underexplored So study aimed see impact MTM medication adherence HRQoL among nondialysis CKD patients prospective openlabelled randomizationcontrolled study conducted among CKD nondialysis patients HRQoL assessed using KDQoL36 questionnaire Medication adherence assessed using medication adherence scale assessed baseline 6supthsup 12supthsup month follow up MTM group received clinical pharmacists MTM service along usual care UC UC group received hospital teams general care Doctors Nurses health care professionals total 220 CKD patient enrolled group 11 ratio baseline patient medium adherence MTM 82 7454 UC 77 70 groups followed low adherence p value 0131 6supthsup 12supthsup month followup Medication adherence increased MTM group compared UC group p value 0001 baseline HRQoL score found domain symptoms problem list MTM 704 UC group 715 p value 005 HRQoL score 5 domain significantly increased 6th month 12th month MTM group compared UC group p value 005 Study concluded MTM service increased medication adherence HRQoL CKD non dialysis patient MTM group compared UC group future MTM service implemented healthcare settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803979/",
        "source_type": "Global"
    },
    {
        "pmid": "40803826",
        "title": "Rest, shade, hydration and hygiene for the prevention of kidney injuries and inflammation in a Nicaraguan sugarcane worker cohort.",
        "abstract": "study effect progressively enhanced restshadehydrationhygiene RSHH intervention kidney injury inflammation biomarkers rate clinical acute kidney injury AKI Nicaraguan sugarcane worker high rate chronic kidney disease nontraditional origin CKDnt analysed serum creatinine Creactive protein CRP leukocyturia sample obtained end four harvest season H14 increase creatinine≥030 mgdL harvest considered incident kidney injury IKI Rates clinically diagnosed AKI obtained medical records season RSHH intervention included progressively longer frequent rest period improved access shade hydration implementation monitoring qualitative interview health outcome assessments 1044 worker followed 1938 personharvests Among burned cane cutters job group highest workload worst outcome initially decreasing rate IKI 21 H1 1 H4 p001 AKI 201000 workermonths 81000 workermonths p001 endharvest leukocyturia 26 1 p001 less rise crossharvest CRP median 175fold increase H1 100 H4 p001 Kidney outcome among outdoor heatstressed worker high risk CKDnt improved structured RSHH intervention implemented committed workplace management finding support causal relationship occupational heat stress kidney injury CKDnt point possibility prevention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803826/",
        "source_type": "Global"
    },
    {
        "pmid": "40803598",
        "title": "The Association of Repair Timing on Outcomes following Thoracic Endovascular Aortic Repair for Intramural Hematoma.",
        "abstract": "Intramural hematoma IMH carry significant risk morbidity mortality although thoracic endovascular aortic repair TEVAR increasingly utilized treatment optimal timing intervention remains uncertain study aim compare outcome patient undergoing urgent TEVAR within 24 hour admission receiving elective TEVAR beyond 24 hour admission Patients underwent TEVAR aortic zone 2 5 IMH 2013 2023 included excluding rupture Propensity score generated using covariates age sex race obesity anemia transfer status hypertension diabetes prior myocardial infarction congestive heart failure smoking history chronic obstructive pulmonary disease cerebrovascular disease dialysis status medication use previous aortic surgery adjust assignment urgentemergent elective TEVAR Perioperative outcome assessed using inverse probabilityweighted logistic regression Association urgent elective TEVAR 5year mortality assessed using Cox regression stratified IMH symptom status Among 345 patients 165 48 underwent elective repair urgent group higher rate transfer outside institution 64 vs 43 p001 less likely use betablockers presentation 69 vs 84 p0003 frequently symptomatic presentation 98 vs 72 p0001 significant difference IMH disease extent graft landing zone groups Perioperative mortality 63 vs 06 adjusted aOR 19 95 CI 301764 p002 reintervention index admission 83 vs 24 aOR 492 95 CI 167195 p001 significantly greater urgent group Fiveyear survival lower urgent group statistically significant symptomatic patients urgent cohort significantly higher perioperative mortality 73 vs 08 aOR 10 95 CI 211152 p002 acute kidney injury 90 vs 25 aOR 328 95 CI 112121 p004 reintervention 85 vs 25 aOR 526 95 CI 161256 p001 Conversely elective group longer total length stay 32 vs 21 aOR 048 95 CI 028082 p001 Fiveyear survival symptomatic cohort lower urgent group statistically significant Patients undergoing urgent TEVAR IMH experience worse perioperative outcome compared undergoing elective repairs despite comparable baseline risk profiles emergent repair may necessary certain cases data advocate patient management strategy prioritizes stabilization intervention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803598/",
        "source_type": "Global"
    },
    {
        "pmid": "40803260",
        "title": "Epidemiology and risk factors of invasive pulmonary fungal disease in patients with lung cancer.",
        "abstract": "Patients lung cancer exhibit heightened susceptibility invasive pulmonary fungal disease IPFD due malignancyassociated immunosuppression Current data pathogen distribution profile IPFD population remain limited study investigated epidemiological distribution fungal pathogen causing IPFD patient lung cancer aim guiding clinical management conducted retrospective analysis consecutive patient lung cancer treated Second Hospital Shanxi Medical University June 2019 May 2024 Patients included discharge diagnosis IPFD received antifungal therapy presented microbiological evidence fungal infection patient diagnosed according 2007 Revised Consensus Pulmonary Fungal Infections Demographic clinical laboratory data collected Univariate multivariate logistic regression analysis employed identify independent IPFD risk factors 1274 lung cancer 92 proven probable IPFD Candida spp 574  Aspergillus spp 353  predominant pathogens sputum 7794  bronchoalveolar lavage fluid 1765  tissue 441  specimen sources Multivariate analysis identified following independent risk factor IPFD lung cancer hypertension OR508 95 CI 1411828 P  0013 chronic respiratory disease OR313 95 CI 114856 P  0026 bone marrow suppression OR272 95  CI 117633 P  0020 multiple comorbidities OR268 95  CI 102709 P  0046 smoking OR247 95 CI 108564 P  0032 Candida Aspergillus specie common causative agent IPFD patient lung cancer However emergence less common fungi Geotrichum capitatum Rhizopus microsporus observed increasing frequency study warrant heightented clinical vigilance Recognizing key risk factors including chronic respiratory diseases male sex hypertension multiple comorbidities smoking may guide early diagnosis targeted antifungal therapy ultimately improving clinical outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803260/",
        "source_type": "Global"
    },
    {
        "pmid": "40802676",
        "title": "Renal Denervation: A New Era in the Management of Resistant Hypertension.",
        "abstract": "Hypertension one leading cause mortality related cardiovascular disease Since advent modern medicine multitude effort made achieve better blood pressure control However despite wide range monitoring protocol medication therapies 23 patient hypertension achieve blood pressure control1 Renal Denervation RDN emerged adjunctive therapy medication lifestyle modification blood pressure control Two method RDN approved US Department Food Drug Administration 2023 Radiofrequency Ablation RFA ultrasoundbased method RFA employ heatgenerating electrode placed renal artery via catheter delivers heat alternating current2 Ultrasoundbased technique us ultrasonic heating create ring ablative energy interrupt renal nerve signaling last two decades wellconducted randomized sham control trial registry analysis proven RDN effective safe treatment option resistant hypertension promising results RDN also becomes appealing chronic kidney disease CKD patient underlying sympathetic overactivity3 article aim provide comprehensive review RDN including current evidence implication routine clinician practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802676/",
        "source_type": "Global"
    },
    {
        "pmid": "40802441",
        "title": "Chronic kidney disease patient safety in hemodialysis: evidence of scale validity and reliability.",
        "abstract": "analyze evidence validity reliability Chronic Kidney Disease Patient Safety Assessment Scale Hemodialysis Sessions EASPRCH methodological study analysis validity evidence content construct reliability temporal stability internal consistency parameterization total 11 judge 240 patient three hemodialysis clinic participated EASPRCH consists 15 item distributed across three domains 1 Strategic Procedures Error Prevention 6 items 2 Organizational Processes Health Management 5 items 3 Care Practices Infection Control 4 items scoring available domain overall scale maximum score 45 point cutoff point adequateinadequate 34 achieved Cronbachs alpha 078 explained 7241 total variance scale provides evidence weakness strength related specific indicators may may impact patient safety hemodialysis care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802441/",
        "source_type": "Global"
    },
    {
        "pmid": "40802428",
        "title": "Knowledge and practices of conservative treatment of chronic kidney disease in the perception of elderly women.",
        "abstract": "understand knowledge practice conservative treatment chronic kidney disease perspective elderly women descriptive qualitative study carried Nephrology outpatient clinic public referral hospital city Recife PE Brazil 21 elderly women Data collection took place January July 2023 semistructured interview composed two guiding questions What understand chronic kidney disease What care take treatment interview recorded analyzed help Iramuteq® software Manifest Content Analysis used analyze data presented Descending Hierarchical Classification Similarity Analysis five thematic category identified difficulty understanding communicating health condition superficial knowledge insecurity severity kidney disease eating practice dietary restrictions selfcare practice health management monitoring laboratory tests study identified elderly woman limited knowledge conservative treatment chronic kidney disease influenced social economic educational barriers need accessible public policy educational strategy support care highlighted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802428/",
        "source_type": "Global"
    },
    {
        "pmid": "40801823",
        "title": "The Synergistic Treatment of Heart and Kidney Disease.",
        "abstract": "incidence prevalence cardiac renal disease Germany steadily rising Heart disease common cause death especially among people chronic kidney disease Impaired kidney function increase risk cardiovascular events vice versa narrative review based pertinent publication retrieved literature search year 2025 particular attention guideline Association Scientific Medical Societies Germany Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften AWMF European Society Cardiology ESC Supplementary search conducted individual aspect epidemiology diagnosis treatment heart kidney disease heart kidney closely pathophysiologically linked damaged shared vascular risk factors including diabetes mellitus arterial hypertension chronic inflammation shared mechanism give rise continuum diseases Multiple RCTs shown recent year morbidity mortality patient heart kidney disease significantly lowered treatment ACE inhibitors also sodiumglucose cotransporter 2 SGLT2 inhibitors glucagonlike peptide 1 receptor agonist GLP1RA nonsteroidal mineralocorticoid receptor antagonist nsMRA Absolute risk reduction range 18 67 found achievable combined endpoint studied depending particular active substance used Heart kidney disease often arise together treated new pharmacotherapeutic strategies Open question remain concerning potential synergistic effect drug mentioned above suitable management polypharmacy enabling costeffective care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801823/",
        "source_type": "Global"
    },
    {
        "pmid": "40800124",
        "title": "The prognostic implications of comorbidities in septic arthritis.",
        "abstract": "Septic arthritis SA orthopedic emergency characterized joint inflammation secondary infectious etiologies commonly iStaphylococcus aureusi prompt recognition SA crucial due significant morbidity mortality Fever along swollen painful joint limited range motion typical manifestations however presentation vary incidence SA adult population rising accompanied unfavorable mortality rates trend exacerbated comorbid condition substantially influence outcomes Among literature diabetes mellitus DM rheumatoid arthritis RA chronic kidney disease CKD emerged key prognostic factor SA DM exacerbates severity SA impairment polymorphonuclear function ultimately leading increased susceptibility infection higher risk acquiring infection atypical pathogens CKD cause uremiainduced immune dysfunction leading immunocompromised state well repeated vascular access increasing infection susceptibility leading increased mortality Patients RA harbor elevated risk SA attributed immune dysregulation immunosuppressive therapy diagnostic challenges Additionally comorbidities complicate surgical management SA increase likelihood treatment failure Therefore given rising burden comorbid condition worldwide impact SA prognosis healthcare professional remain vigilant managing factors holistic multidisciplinary approach management vital ensure SA patient certain comorbid condition experience fewer complication improved survival minireview aim highlight key comorbid condition impact prognosis SA patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40800124/",
        "source_type": "Global"
    },
    {
        "pmid": "40799827",
        "title": "Factors that influence the Na/K-ATPase signaling and function.",
        "abstract": "transmembrane NaKATPase located plasma membrane mammalian cells utilizes energy ATP hydrolysis execute pumping function interacts protein andor kinase molecule execute signaling function Digoxin one earliest identified cardiotonic steroid CTS specifically bind NaKATPase widely prescribed manage patient cardiovascular disease CVD heart failure HF 200 years Elevated plasma level CTS observed patient hypertension chronic kidney disease CKD CVD congestive HF extensive research effort spanning decades remain unresolved disagreement regarding various mechanism underlying NaKATPase signaling functions article examines known controversial mechanism initiate NaKATPase signaling function related regulatory mechanisms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799827/",
        "source_type": "Global"
    },
    {
        "pmid": "40799824",
        "title": "The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial.",
        "abstract": "Chronic kidney disease CKD patient high prevalence mortality rates however current treatment option remain limited Shenkang suppository SKS traditional Chinese medicine used clinical management CKD Increasing evidence suggests close relationship gut microbiome CKD aimed investigate impact SKS kidney function gut microbiota CKD stage 34 patients singlecenter randomized controlled trial n  80 CKD stage 34 patient randomly assigned 11 ratio either control group n  40 SKS group n  40 followed 8 weeks Baseline data clinical indicators kidney markers stool sample obtained participant treatment bacterial DNA isolated fecal sample analyzed via highthroughput 16S rRNA sequencing total 34 patient SKS group 36 control group completed study Kidney function control group significantly worsened 8 week iP  005i whereas SKS positive effect slowing progression kidney function decline 8 week SKS intervention beneficial bacteria Coriobacteriaceae RuminococcaceaeiRuminococcusi proliferated dramatically whereas abundance harmful bacteria Veillonellaceae decreased Linear discriminant analysis LDA revealed SKS treatment increased proportion iStreptococcusi decreased proportion Planctomycetes Spirochaetes Rhodocyclales Actinomycetaceae Veillonellaceae Dechloromonas change observed control group Correlation analysis revealed negative association iBifidobacteriumi iBlautiai EnterococcaceaeiEnterococcusi clinical kidney function indicators whereas iParabacteroidesi iAcinetobacteri iSutterellai iOscillospirai iAlistipesi positively correlated kidney function SKS could delay progression kidney function CKD stage 34 patients possibly modulating dysbiosis gut microbiota close association certain gut microbiota clinical kidney function indicator suggest gut microbiota could serve new therapeutic target CKD httpswwwchictrorgcn Chinese Clinical Trial Registry Identifier ChiCTR2200058493",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799824/",
        "source_type": "Global"
    },
    {
        "pmid": "40799007",
        "title": "Association between consumption of different food groups and risk of chronic kidney disease: A dose-response meta-analysis of prospective cohort studies.",
        "abstract": "light varying outcome prior research concerning relationship different food group risk chronic kidney disease CKD study conducted examine relationship consumption various food group CKD risk via dosedependent metaanalysis prospective cohort studies Searches conducted Web Science PubMed Google Scholar database January 2025 6460 publications twentyone study selected final analysis result revealed red meat consumption associated increased risk CKD RR 139 95 CI 113 171 Conversely consumption fish RR 088 95 CI 080 097 grain RR 087 95 CI 077 099 legume RR 083 95 CI 072 092 showed protective effect CKD linear doseresponse analysis indicated every 100 gday increment red meat total meat consumption risk CKD escalated 34 2 respectively Furthermore increase 15 gday dietary fish 28 gday nuts 50 gday legume associated 6 21 13 decreased risk CKD respectively Overall higher red meat intake correlate heightened CKD risk whereas consumption fish grains legume associated lowered risk longitudinal cohort study extended followup recommended validate findingsThis trial registered PROSPERO CRD42023465532",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799007/",
        "source_type": "Global"
    },
    {
        "pmid": "40797423",
        "title": "Neutrophil-to-albumin ratio for predicting mortality in chronic kidney diseases: A cohort study on all-cause and cardiovascular mortality from NHANES 1999 to 2018.",
        "abstract": "Chronic kidney disease CKD significantly impact quality life survival patient globally neutrophiltoalbumin ratio NAR scoring system reflects inflammation nutritional mortality risk chronic diseases study aim evaluate role NAR predicting CKD mortality Data NHANES 1999 2018 analyzed participant grouped NAR quartiles COX regression KaplanMeier curve used examine CKD mortality Piecewise restricted cubic spline analysis COX regression assessed nonlinear relationship NAR mortality alongside piecewise subgroup analyses total 6042 participant included Q4 exhibited significantly higher allcause mortality 2469 v 3392 P  001 cardiovascular disease CVD mortality 1109 v 1495 P  028 compared Q1 KaplanMeier curve showed Q4 lowest survival rate Logrank P  001 final adjusted model Model 2 Q4 significantly higher allcause HR  153 95 CI  135174 P  001 CVD mortality HR  154 95 CI  124192 P  003 nonlinear relationship found NAR allcause P  001 P nonlinear  005 CVD mortality P  001 P nonlinear  038 higher risk NAR ≥ 19 study identified complex nonlinear relationship NAR CKD mortality NAR level negatively correlating survival probability particularly higher range specific highrisk populations finding support use NAR tool assessing CKD mortality risk providing insight early prevention prognosis assessment management CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797423/",
        "source_type": "Global"
    },
    {
        "pmid": "40797230",
        "title": "Pregnancy-associated acute kidney injury as an important driver of chronic kidney disease in females in developing countries: A systematic review.",
        "abstract": "Pregnancyrelated AKI PRAKI profound maternal fetal implications including high mortality longterm risk development chronic kidney disease CKD systematic review aim evaluate burden CKD owing PRAKI case followup developing countries particularly India systematic search PubMed Embase Cochrane database performed Indian study published 2000 June 2024 included crosssectional retrospective prospective cohort study reported incidence PRAKI subsequent CKD dialysis dependency Indian cohort followup Details etiology PRAKI adverse fetal maternal outcome also recorded study provided followup kidney outcome considered total 25 study comprising 2306 participant included analysis incidence PRAKI ranged 1 12 across different studies Sepsis common cause PRAKI accounting 78 cases followed hypertensive disorders obstetric haemorrhage tropical etiologies Hemodialysis required 2085 patients CKD development followup observed 12835 cases 30 remaining dialysisdependent Maternal mortality ranged 25 34 perinatal mortality reached high 673 Preterm delivery rate varied 139 58 onethird PRAKI patient may develop CKD remain dialysisdependent followup PRAKI significantly impact maternal fetal morbidity mortality Early prevention prompt management healthcare professional critical improving outcome PRAKI Pregnancyrelated acute kidney injury PRAKI significantly affect maternal fetal health leading high mortality longterm complication chronic kidney disease CKD systematic review focusing developing country like India evaluated burden CKD due PRAKI patients review analyzed Indian study published 2000 June 2024 including 25 study 2306 participants PRAKI incidence ranged 1 12 sepsis leading cause 78 cases followed hypertensive disorders obstetric hemorrhage tropical fevers RRT needed 2085 patients 12835 developed CKD followup 30 remaining dialysisdependent Maternal mortality varied 25 34 perinatal mortality reached 673 study emphasizes critical need early prevention timely intervention need longterm followup reduce high morbidity mortality rate associated PRAKI",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797230/",
        "source_type": "Global"
    },
    {
        "pmid": "40796290",
        "title": "What do clinical trials teach us about the pathophysiology of human IgA nephropathy?",
        "abstract": "Immunoglobulin nephropathy IgAN primary glomerulonephritis characterized IgAdominant codominant mesangial immune deposit seen routine immunofluorescence staining kidney biopsy tissue Approximately 40 patient develop kidney failure within ten year diagnosis IgAN variable clinical presentation ranging characteristic synpharyngitic macroscopic hematuria persistent microscopic hematuria without proteinuria often accompanied reduced kidney function disease recognition delayed Recent data UK National Registry Rare Kidney Diseases underscore need early diagnosis prompt management stringent proteinuria reduction avoid kidney failure throughout affected patients lifetime recently paucity disease specific treatment options However elucidation IgAN pathophysiology data genome wide association study Kidney Health Initiative that identified change proteinuria acceptable surrogate endpoint clinical trials revolutionized IgAN therapeutic landscape Beyond systemic steroids targeted release formulation budesonide thought act primarily gutassociated lymphoid tissue reduce production pathogenic galactosedeficient IgA1 first United States Food Drug Administration approved IgAN treatment B cell plasma cell play central role production galactosedeficient IgA1 autoantibody targeted using Bcell Activating Factor ProliferationInducing Ligand cytokine inhibitor well CD38  plasma cell depleting drugs Recognizing role alternative complement cascade IgAN mediated glomerular injury inflammation identified new potential therapeutic target ultimately led approval complement Factor B inhibitor iptacopan nonimmunosuppressive treatment also available investigated aim reducing proteinuria slowing chronic kidney disease progression including endothelin receptor antagonists paper review current clinical trial IgAN critically examine teach u IgAN pathogenesis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796290/",
        "source_type": "Global"
    },
    {
        "pmid": "40796264",
        "title": "Type 2 diabetes in South Asians.",
        "abstract": "Type 2 diabetes pose substantial public health challenge South Asia marked distinctive feature pathogenesis phenotype management review explores characteristic type 2 diabetes South Asians tend develop condition younger average age lower body mass index white populations Prevalence high varies across region recent increase youth onset type 2 diabetes Environmental influence driving greater sedentary behavior dietary shift towards processed food leading higher body weights concerning South Asians show greater abdominal obesity ectopic fat accumulation particularly hepatic fat lower skeletal muscle mass white people similar age body mass index features coupled rapid β cell dysfunction contribute earlier onset accelerated glycemia progression greater aggregated hyperglycemia white people contributing retinopathy cardiovascular disease chronic kidney disease Management type 2 diabetes region hindered delayed diagnosis inadequate healthcare access economic barrier limiting sustainable glucose lipid blood pressure management Evidence support lifestyle dietary weight loss viable approach prevention diabetes remission respectively though sustained remission untested Recently introduced drug sodiumglucose cotransporter 2 inhibitor newer glucagonlike peptide 1 receptor agonists offer promise weight management cardiovascular kidney protection often inaccessible owing cost constraints Future effort prioritize affordable innovative solutions strengthen healthcare systems implement population wide preventive measure account regions socioeconomic complexities practical contextual research",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796264/",
        "source_type": "Global"
    },
    {
        "pmid": "40795933",
        "title": "MRI-Based Stratification and Surgical Management of Hydrocolpos in Children and Adolescents.",
        "abstract": "report present new anatomical stratification vaginal obstruction hydrocolpos based MRI finding referring level obstruction fixed bony landmark the pubic symphysis new approach overcome limitation current classifications prone approximation error measurement fail account variation body mass across different age groups Data case diagnosed vaginal obstruction retrospectively analysed Cases cloaca vaginal obstruction excluded MRI confirmed diagnosis enabled classification level vaginal obstruction relative pubic symphysis midsagittal plane low intermediate highopposite lower mid upper end pubic symphysis respectively Thirteen girl presented vaginal obstruction period 2010 2024 age ranged 1 month 14 year mean 54 months median 18 months Three case presented neonatal period antenatal diagnosis hydrocolpos six case referred later infancychildhood centers Another group adolescent girl 4 cases presented clinical picture cryptomenorrhea cause vaginal obstruction imperforate hymen one vaginal atresia six persistent urogenital sinus five cases one case obstructed hemivagina series six case 46 feature related genetic syndrome Bardet Biedl McKusickKaufman spectrum Chronic parenchymatous renal disease present 3 case among syndromic feature Bardet Biedl syndrome addition another case Obstructed left hemivagina absent left kidney HerlynWernerWunderlich syndrome Surgical technique included simple excision distal obstructing membrane 4 cases abdominal assisted vaginoplasty 2 cases vaginal pullthrough 4 cases simple introitoplasty 1 case urogenital sinus mobilization 1 case division longitudinal vaginal septum case obstructed hemivagina Vaginal stenosis retraction occurred three case intermediate highlevel obstructiontwo following abdominalassisted vaginoplasty one vaginal pullthrough MRIbased stratification vaginal obstruction using pubic symphysis reference provides practical reproducible approach surgical planning",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795933/",
        "source_type": "Global"
    },
    {
        "pmid": "40795345",
        "title": "Occupational Risk Factors for Kidney Disease: A Comprehensive Review.",
        "abstract": "Chronic kidney disease CKD major global health concern traditional risk factor diabetes hypertension well established However emerging evidence suggests occupational exposure could play significant role CKD development review comprehensively summarizes current evidence concerning occupational risk factor contributing kidney disease including exposure heavy metal lead cadmium mercury chromium organic solvent trichloroethylene methanol ethylene glycol heat stress jobrelated stress factor occupational stress long working hours shift work Epidemiological study indicate nephrotoxic agent contribute renal dysfunction oxidative stress mitochondrial damage impaired ion transport Industries manufacturing agriculture mining pose particularly high risk due hazardous exposures strong evidence link nephrotoxic metal solvent early renal dysfunction longterm effect chronic lowdose exposure remain unclear Additionally heat stressrelated CKD particularly MesoAmerican nephropathy highlight growing concern climaterelated occupational risks Jobrelated stress factors including long working hour shift work may accelerate CKD progression stressinduced hypertension metabolic disturbances Given substantial public health implications preventive strategy focus reducing workplace exposures implementing heat stress management programs addressing impact jobrelated stress factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795345/",
        "source_type": "Global"
    },
    {
        "pmid": "40795063",
        "title": "Enhancing end-stage renal disease outcome prediction: a multisourced data-driven approach.",
        "abstract": "improve prediction chronic kidney disease CKD progression endstage renal disease ESRD using machine learning ML deep learning DL model applied integrated clinical claim data varying observation windows supported explainable artificial intelligence AI enhance interpretability reduce bias utilized data 10 326 CKD patients combining clinical claim information 2009 2018 preprocessing cohort identification feature engineering evaluated multiple statistical ML DL model using 5 distinct observation windows Feature importance SHapley Additive exPlanations SHAP analysis employed understand key predictors Models tested robustness clinical relevance misclassification patterns bias Integrated data model outperformed single data source models long shortterm memory achieving highest area receiver operating characteristic curve AUROC 093 F1 score 065 24month observation window optimally balanced early detection prediction accuracy 2021 estimated glomerular filtration rate eGFR equation improved prediction accuracy reduced racial bias particularly African American patients Improved prediction accuracy interpretability bias mitigation strategy potential enhance CKD management support targeted interventions reduce healthcare disparities study present robust framework predicting ESRD outcomes improving clinical decisionmaking integrated multisourced data advanced analytics Future research expand data integration extend framework chronic diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795063/",
        "source_type": "Global"
    },
    {
        "pmid": "40795012",
        "title": "Impact of Twice-weekly Scheduled Dialysis Through the Emergency Department for Patients with End-stage Renal Disease.",
        "abstract": "Patients endstage renal disease ESRD access standard dialysis often rely emergencyonly dialysis EOD emergency department ED Compared standard dialysis EOD lead higher hospitalization rates hospital days higher mortality objective study examine hospitalization rate total hospital day transitioning patient ESRD ED EOD scheduled ED dialysis subsequently standard outpatient dialysis performed retrospective study single academic teaching hospital course 10 year 20142023 Patients 18 year age received dialysis primarily ED one year included study studied two cohorts Cohort 1 consisted patient ESRD transitioned ED EOD twiceweekly ED dialysis Cohort 2 composed patient transitioned twiceweekly ED dialysis standard outpatient dialysis performed paired patient analysis using Wilcoxon signedrank test Primary outcome included hospitalization per month total hospital days Overall seven patient cohort 1 mean age 39 years 86 female 20 patient cohort 2 mean age 44 50 female Patients transitioned twiceweekly ED dialysis ED EOD lower hospitalization per month 144 v 026 P 05 fewer total hospital day per month 218 v 120 P  05 Patients transitioned twiceweekly scheduled ED dialysis standard outpatient dialysis even lower hospitalization per month 010 v 002 P  01 total hospital day 031 v 008 P  01 Introducing scheduled twiceweekly ED dialysis session unfunded patient endstage renal disease associated lower overall hospitalization rate hospital day emergencyonly dialysis measure decreased transitioning patient ED scheduled dialysis standard dialysis",
        "mesh_terms": [
            "Humans",
            "Kidney Failure, Chronic",
            "Emergency Service, Hospital",
            "Female",
            "Male",
            "Retrospective Studies",
            "Renal Dialysis",
            "Adult",
            "Hospitalization",
            "Middle Aged",
            "Length of Stay",
            "Appointments and Schedules"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795012/",
        "source_type": "Global"
    },
    {
        "pmid": "40794410",
        "title": "Work Impairment and Financial Outcomes Among Adults With vs Without Long COVID.",
        "abstract": "much focus long COVID LC defined developing new persistent symptom lasting 3 month longer SARSCoV2 infection health status quality life impact individual work productivity financial distress less well established assess difference work financial outcome among individual current resolved LC 3 year initial infection prospective multisite longitudinal cohort study enrolled adult participant age ≥18 years least 1 reported SARSCoV2 infection December 7 2020 August 29 2022 Followup electronic survey collected April 2 2024 Data analyzed January 20 February 4 2025 Selfreported resolved current LC vaccination status Financial toxicity measured using Comprehensive Score Financial ToxicityFunctional Assessment Chronic Illness Therapy FACITCOST work impact measured using Work Productivity  Activity Impairment questionnaire version 20 3663 participant mean SD age 402 142 years 2429 663 female 994 271 reported current LC 2604 711 never LC 65 18 resolved LC Participants current LC reported overall work impairment due health mean SD 177 253 total hour worked per week compared never LC mean SD 32 118 total hours resolved LC mean SD 56 122 total hours significantly increased odds work impairment compared never LC adjusted odds ratio aOR 724 95 CI 568921 current LC group increased odds missing work due health aOR 262 95 CI 193357 experiencing work impairment aOR 1182 95 CI 8901570 compared group never LC Individuals current LC increased odds moderate high FACITCOST score compared never LC aOR 520 95 CI 392689 compared resolved LC aOR 316 95 CI 119841 Participants vaccinated lower overall work impairment aOR 071 95 CI 055092 impairment working aOR 066 95 CI 050087 impairment nonwork activity aOR 074 95 CI 057096 financial toxicity leastsquares mean difference 107 95 CI 019195 compared vaccinated prospective cohort study adult SARSCoV2 infection participant current selfreported LC reported worse work impairment missed work financial distress compared never LC vaccination associated improved work outcome less financial distress even among individual LC data underscore need postpandemic assistance programs well vaccination decrease societal harms",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "COVID-19",
            "Adult",
            "Middle Aged",
            "Prospective Studies",
            "Longitudinal Studies",
            "SARS-CoV-2",
            "Quality of Life",
            "Efficiency",
            "Surveys and Questionnaires",
            "Financial Stress"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794410/",
        "source_type": "Global"
    },
    {
        "pmid": "40794339",
        "title": "Optimizing Care for Cardiovascular-Kidney-Metabolic Syndrome: Leveraging Implementation Science in the Path Toward Pharmacoequity.",
        "abstract": "Overview current landscape pharmacoequity cardiovascularkidneymetabolic CKM syndrome CKM syndrome key driver significant morbidity mortality associated cardiovascular disease pose significant threat public health Despite growing armamentarium evidencebased therapy prevention management CKM syndrome access treatment remains unequal instance gender race ethnicitybased disparity noted use firstline guidelinedirected diseasemodifying drugs Barriers pharmacoequity CKM including multimorbiditypolypharmacy low awareness clinical inertia cost pharmacy inaccessibility unequal sociocontextual factors fragmented care require urgent attention including equitypromoting policy​​ Individual systemlevel barrier pharmacoequity CKM syndrome impede optimal CKM management particularly among minoritized populations describe multifaceted multilevel approach CKM equity including interdisciplinary care clinical decision support tool designed implementation science lens may help combat inequities",
        "mesh_terms": [
            "Humans",
            "Metabolic Syndrome",
            "Cardiovascular Diseases",
            "Implementation Science",
            "Cardio-Renal Syndrome",
            "Healthcare Disparities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794339/",
        "source_type": "Global"
    },
    {
        "pmid": "40793887",
        "title": "[Economic impact of diabetes and its main complications in Argentina].",
        "abstract": "Cardiovascular disease leading cause mortality patient type 2 diabetes mellitus T2DM weighted prevalence argentine patient 415The aim study estimate direct medical cost associated treatment followup T2DM addition main chronic complications Microcosting analysis calculate estimate frequency resource use determine overall cost Argentine peso ARS August 2022 T2DM related complication described Argentinean population CAPTURE study estimated annual direct cost followup treatment T2DM per patient ARS 252 89945 United States dollar USD 177448 social security subsector ARS 257 79910 USD 180886 private subsector Stroke expensive diabetesrelated complication complexity care increased relative decrease medication cost concomitant increase cost interventions considering cost treatment uncomplicated T2DM baseline parameter cardiovascular renal cerebrovascular event multiplied value 99 84 478 times respectively significant economic burden T2DM complication Argentine healthcare system social security private sectors highlight importance understanding cost make effective strategic decision regarding disease management population health policy planning",
        "mesh_terms": [
            "Humans",
            "Argentina",
            "Diabetes Mellitus, Type 2",
            "Female",
            "Cardiovascular Diseases",
            "Male",
            "Middle Aged",
            "Health Care Costs",
            "Diabetes Complications",
            "Cost of Illness",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793887/",
        "source_type": "Global"
    },
    {
        "pmid": "40792415",
        "title": "Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta-analysis.",
        "abstract": "Heart failure HF multifactorial disease peak oxygen uptake VOsub2subpeak may potentially prognostic marker adverse clinical outcomes systematic review metaanalysis aimed assess published data prognostic impact VOsub2subpeak HF literature search observational study conducted PubMed Scopus Web Science Cochrane Library inception January 2025 metaanalysis conducted using randomeffects inversevariance model hazard ratio HRs Increased heterogeneity among study evaluated metaregressions publication bias via Eggers test Sixtyfour study included systematic review metaanalysis Per 1 mLkgmin increase VOsub2subpeak allcause mortality HR 086 95 confidence interval CI 082090 Isup2sup  85 P  001 incident ventricular assist device transplant allcause mortality HR 084 95 CI 079089 Isup2sup  33 P  001 significantly reduced statistical significance VOsub2subpeak cardiovascular mortality observed HR 092 95 CI 082102 Isup2sup  0 P  012 using adjusted models Variance among study detected based age sex body mass index left ventricular ejection fraction atrial fibrillation hypertension chronic kidney disease diabetes treatment significant risk publication bias evident VOsub2subpeak prognostic marker multiple cause mortality hospitalization patient HF may promote insight patient risk stratification adverse event targeted management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792415/",
        "source_type": "Global"
    },
    {
        "pmid": "40792246",
        "title": "Enhancing the use of sodium-glucose cotransporter-2 inhibitors in type-2 diabetic patients with chronic kidney disease, through a key performance indicator program.",
        "abstract": "Despite substantial clinical evidence recommendation international society supporting use sodiumglucose cotransporter2 inhibitor SGLT2i managing patient type2 diabetes T2D chronic kidney disease CKD adoption remained limited address this nephrology quality improvement QI team Hamad Medical Corporation HMC Qatar implemented key performance indicator KPI program March 2022 aiming ensure least 80 eligible T2DCKD patient HMC receiving SGLT2i December 31 2023 use SGLT2i angiotensinconverting enzyme inhibitor ACEi angiotensin II receptor blocker ARB T2DCKD patient attending nephrology clinic HMC hospital assessed retrospective survey using clusterbased sampling approach Nephrology physician updated result retrospective survey well evidence SGLT2i trial guidelines aims objectives target KPI program clearly defined Three additional survey conducted 6month intervals multifaceted QI intervention approachcombining audit feedback leadership engagement peer consultationwas implemented drive improvement Retrospective survey conducted November 2021 February 2022 revealed 38 44 eligible T2DCKD patient receiving SGLT2i therapy compared 98 99 ACEiARB Four month implementing KPI program July 2022 survey revealed change SGLT2i use 41 ACEiARB prescription rate remained near 100 Following QI intervention November 2022 February 2023 survey revealed significant increase SGLT2i use rising 88 SGLT2i initiation naive patient increasing 34 61 final survey conducted August 2023 showed 84 patient receiving SGLT2i therapy KPI program boosted SGLT2i prescription rate eligible T2DCKD patient nephrology clinics resulting 47 rise 41 88 overcame prescription inertia accelerated guideline adoption combining realtime feedback leadership engagement peer discussions sharp rise new prescription following November 2022 feedback underscore direct influence behavior modification rather broader trend",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792246/",
        "source_type": "Global"
    },
    {
        "pmid": "40791237",
        "title": "Differential effects of plant protein ratio on renal function and mortality across CKD stages.",
        "abstract": "plant protein suggested offer renoprotective benefits optimal proportion dietary plant protein relationship outcome across different stage chronic kidney disease CKD remains unclear Using data National Health Nutrition Examination Survey NHANES examined association plant protein ratio estimated glomerular filtration rate eGFR across CKD stages Plant protein ratio categorized low  33 medium 3366 high ≥ 66 Multiple imputation performed missing data Weighted linear regression model used analyze plant protein ratioeGFR associations Cox proportional hazard model assessed mortality risk Doseresponse relationship evaluated using restricted cubic splines Among 16163 participants distinct pattern emerged across CKD stages NonCKD high plant protein ratio associated significantly higher eGFR compared low plant protein ratio β  0790 iPi  0039 CKD G4 medium plant protein ratio showed significantly higher eGFR β  1791 iPi  0025 compared low plant protein ratio mortality risk CKD G3 patient medium plant protein ratio demonstrated significantly lower risk HR  067 95 CI 044100 iPi  0047 compared low plant protein ratio Doseresponse analysis revealed stagespecific patterns Ushaped relationship early CKD transitioning inverted Ushaped Jshaped pattern advanced stages association plant protein ratio outcome varies across CKD stages suggesting need stagespecific dietary recommendations moderate plant protein intake might beneficial early CKD finding advanced stage largely nonsignificant require confirmation larger study clinical recommendation made finding support nuanced approach dietary protein source management CKD though prospective study needed confirm associations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791237/",
        "source_type": "Global"
    },
    {
        "pmid": "40790782",
        "title": "Optimizing care for chronic kidney disease: Considerations from A to Z.",
        "abstract": "Chronic kidney disease CKD management requires comprehensive multidisciplinary approach optimize clinical outcomes review systematically outline essential component CKD care Z offering evidencebased guidance enhance patient management Anemia treatment emphasizes iron supplementation erythropoiesisstimulating agents novel hypoxiainducible factor prolyl hydroxylase inhibitors Achieving optimal blood pressure control reninangiotensin system inhibitor calcium channel blocker reduces cardiovascular risk delay CKD progression Cardiovascular risk management includes statin combined ezetimibe proprotein convertase subtilisinkexin type 9 inhibitors along appropriate anticoagulation therapy atrial fibrillation Individualized glycemic control strategy prioritize sodiumglucose cotransporter2 inhibitor glucagonlike peptide1 receptor agonist cardiovascular renal protective effects Vigilance avoiding nephrotoxic agents nonsteroidal antiinflammatory drugs proton pump inhibitors aminoglycosides contrast media essential preventing renal injury Rigorous management electrolyte acidbase disturbances involving dietary sodium potassium restrictions phosphate binders bicarbonate supplementation reduces CKD progression related complications Appropriate fluid management dietary sodium water restriction individualized diuretic therapy prevents volume overload associated cardiovascular complications Nutritional interventions particularly lowprotein diet supplemented ketoanalogues amino acids effectively delay CKD progression control metabolic disturbances Therapies addressing CKDrelated mineral bone disorders including phosphate binders vitamin analogues calcimimetics reduce risk vascular calcification addition lipidlowering therapies anticoagulation therapy optimal vascular access management dialysis early detection arrhythmia thrombotic microangiopathy significantly enhance patient outcomes Attention qualityoflife issues alleviating xerosis symptoms promoting optimal body mass index weight management strategies providing psychosocial support enhances patientcentered care comprehensive review highlight crucial importance multidisciplinary approach CKD management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790782/",
        "source_type": "Global"
    },
    {
        "pmid": "40790474",
        "title": "From acute kidney injury to chronic kidney disease in children: maladaptive repair and the need for long-term surveillance - a literature review.",
        "abstract": "Pediatric Acute Kidney Injury AKI increasingly prevalent global health concern extends far beyond transient clinical event posing significant risk longterm kidney dysfunction review consolidates current knowledge pathophysiological transition pediatric AKI Chronic Kidney Disease CKD critically evaluating mechanism maladaptive repair utility biomarkers state longterm surveillance strategies progression CKD driven maladaptive repair process kidneys healing mechanism become dysregulated following severe prolonged insult pathological cascade involves persistent inflammation endothelial dysfunction tubular epithelial cell cycle arrest activation myofibroblasts culminating irreversible interstitial fibrosis nephron loss kidney preterm infant neonate particularly vulnerable preterm infant may incomplete nephrogenesis leading reduced nephron endowment neonate exhibit functional immaturity AKI critical early period disproportionately large impact amplifying lifetime risk hypertension accelerated CKD Evidence confirms pediatric AKI survivor face substantially increased risk incident CKD hypertension proteinuria even serum creatinine level return baseline Current diagnostic tools reliant creatinine insensitive lag behind actual injury hindering timely intervention novel biomarkers show promise early AKI detection ability predict transition CKD remains area active investigation Major conclusion review highlight pediatric AKI must reframed sentinel event necessitates longterm approach kidney health However care often fragmented challenge compounded lack pediatricspecific evidencebased followup guidelines Future progress depends dedicated research unique aspect maladaptive repair developing kidneys validation predictive biomarkers development targeted ageappropriate therapies",
        "mesh_terms": [
            "Humans",
            "Acute Kidney Injury",
            "Renal Insufficiency, Chronic",
            "Child",
            "Disease Progression",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790474/",
        "source_type": "Global"
    },
    {
        "pmid": "40790363",
        "title": "Kidney stone disease: risk factors, pathophysiology and management.",
        "abstract": "Nephrolithiasis common health condition affecting kidney urinary tract constitutes major global healthcare problem prevalence nephrolithiasis increased substantially past five decades irrespective age sex ethnicity Kidney stone cause substantial morbidity reduced quality life enormous healthcare expenditure largely due frequent recurrence Furthermore nephrolithiasis recognized systemic condition associated increased risk chronic kidney disease cardiovascular disease metabolic syndrome low bone mass Nephrolithiasis exhibit marked pathophysiological heterogeneity Dietary environmental exposure interact genetic predisposition shape individual disease risk Calcium oxalate stone prevalent commonly driven hypercalciuria hyperoxaluria hypocitraturia low urine volume whereas formation uric acid calcium phosphate stone commonly linked urinary pH comprehensive clinical evaluation uncover underlying metabolic abnormalities distinguish idiopathic secondary Mendelian form nephrolithiasis identify systemic disease association guide therapy Recurrence prevention requires individualized strategy combine dietary pharmacological interventions established stones surgical management effective ureteroscopy percutaneous nephrolithotomy achieving high stonefree rates Despite considerable clinical societal burden nephrolithiasis remains underrecognized underserved underresearched Greater awareness investment research innovation education urgently needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790363/",
        "source_type": "Global"
    },
    {
        "pmid": "40789986",
        "title": "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.",
        "abstract": "Gout inflammatory arthritis caused monosodium urate crystal deposition joints clinical presentation varies age onset study compared clinical feature treatment pattern olderonset gout commonageofonset gout analyzed data Urate Lowering TheRApy Gout registry Eligible participant aged ≥ 18 year met 2015 American College RheumatologyEuropean League Rheumatism classification criterion gout Olderonset gout defined gout diagnosed age 65 years commonageofonset gout gout diagnosed age 65 years Demographics clinical features treatment patterns quality life laboratory finding collected baseline 6 months Among 477 patients 105 220 olderonset gout 372 780 commonageofonset gout olderonset group included woman 257 versus 24 P  0001 showed higher frequency radiographic goutrelated joint damage erosion 305 versus 196 P  0018 comorbidities eg hypertension cardiovascular disease chronic kidney disease malignancy glucocorticoid use flare prophylaxis contrast commonageofonset group higher body mass index BMI frequent flares unhealthier lifestyle habit eg smoking alcohol higher rate nonsteroidal antiinflammatory drug NSAID benzbromarone use Febuxostat frequently prescribed olderonset group 714 versus 589 P  0019 benzbromarone use common commonageofonset group 73 versus 0 P  0004 febuxostat dose lower olderonset group 6 months group showed similar followup adherence flare frequency healthcare utilization Olderonset gout commonageofonset gout distinct clinical characteristics particularly comorbidities lifestyle factors treatment patterns Gout management tailored basis age onset",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789986/",
        "source_type": "Global"
    },
    {
        "pmid": "40788686",
        "title": "Lupus Nephritis: Unmet Needs and Evolving Solutions.",
        "abstract": "Lupus nephritis LN seeing enriching immunotherapies important unmet need remain discus focus histological sign immunological activity triggering immunotherapy versus sign irreversible kidney injury requiring care chronic kidney disease Also correct interpretation residual proteinuria requires dissecting immunological activity glomerular hyperfiltration eg repeat biopsy Despite modern triple immunotherapy perprotocol biopsy still document irreversible injury occur first year Immediate inhibition complement system may address unmet need may even help ultimately replace early glucocoorticoid therapy advocate concept clonedirected therapy sufficiently suppress autoreactive clone memory B cell inside lymphoid tissue well longlived plasma cell bone marrow maintain activity systemic lupus erythematosus SLE drive disease flares Numerous B cell plasma celltargeting therapy gradually becoming available parenteral route application may also avoid oral drug nonadherence Replacing oral toxic medication steroids mycophenolate calcineurin inhibitor goal next decade Obtaining orphan disease designation LN would accelerate progress supported latest data LN prevalence conceptual management improvements LN complex frequently fatal may become easytomanage autoimmune diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788686/",
        "source_type": "Global"
    },
    {
        "pmid": "40788620",
        "title": "Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry.",
        "abstract": "Patients heart failure HF high risk hyperkalaemia underrepresented prospective HF registries CAREHK HF registry sought characterize prospectively clinical profile management outcome patient HF high risk hyperkalaemia CAREHK HF multinational prospective registry outpatient HF regardless left ventricular ejection fraction LVEF treated angiotensinconverting enzyme inhibitorangiotensin II receptor blockerangiotensin receptorneprilysin inhibitor ACEIARBARNI either receiving potential candidate mineralocorticoid receptor antagonist MRA patient increased risk hyperkalaemia defined hyperkalaemia baseline prior hyperkalaemia estimated glomerular filtration rate eGFR 45 mlmin173 msup2sup Outcomes included frequency hyperkalaemic event defined clinician report associated potassium value achievement reninangiotensin system inhibitor RASi optimization defined ≥50 target dos ACEIARBARNI MRA medication change following hyperkalaemic episodes clinical events Overall 2558 patient 111 site across nine country included Median 25th75th age 73 6580 years 32 women 61 LVEF ≤40 40 prior laboratory evidence hyperkalaemia Median baseline eGFR serum potassium 44 3360 mlmin173 msup2sup 50 4453 mEqL respectively median followup 123 94181 months 29 patient hyperkalaemic event 7 multiple events characterizing treatment prescribed followup 29 patient received optimal RASiMRA therapy 69 received suboptimal RASiMRA therapy 3 received RASiMRA 30 day following first hyperkalaemic event RASiMRA downtitrated discontinued 36 cases Potassium binder use low patiromer 91 sodium zirconium cyclosilicate 59 Compared patient without hyperkalaemic event patient experiencing hyperkalaemic event similar risk allcause mortality hazard ratio HR 122 95 confidence interval CI 092162 p  016 higher risk subsequent hospitalization HR 159 95 CI 135186 p  0001 contemporary multinational prospective registry patient HF high risk hyperkalaemia hyperkalaemic event common infrequently associated RASiMRA modification potassium binder use Fewer one three patient received optimal RASiMRA therapy majority followup hyperkalaemic event associated higher risk adverse clinical outcomes ClinicalTrialsgov NCT04864795",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788620/",
        "source_type": "Global"
    },
    {
        "pmid": "40788539",
        "title": "Chronic comorbidities and risk of 30-day mortality in hip fracture patients- a Danish National patient registry study.",
        "abstract": "Hip fracture major health issue among elderly population associated increased mortality Chronic comorbidities may cause increased mortality risk among patients study examined impact chronic comorbidities 30day mortality among Danish hip fracture patient along risk factor sex fracture type study used data Danish National Patient Registry included patient aged ≥ 70 year sustained hip fracture January 1 1999 December 31 2012 Chronic comorbidities dementia heart failure chronic obstructive pulmonary disease asthma ischemic heart disease diabetes mellitus complications chronic kidney disease cancer well fracture type identified using ICD10 codes total 98850 hip fracture patient included 115 died within 30 days Male patient significantly higher 30day mortality rate 177 female patient 92 Patients multiple chronic comorbidities increased mortality risk patient ≥ 5 chronic comorbidities exhibiting 30day mortality rate 283 compared 78 patient without chronic comorbidities Regarding fracture types patient subtrochanteric fracture mortality risk 132 compared patient femoral headneck fracture mortality risk 108 adjusted analysis chronic kidney disease male sex highest association increased 30day mortality risk study show significant impact chronic comorbidities well sex fracture type 30day mortality hip fracture patients Patients multiple chronic comorbidities highest risk increased 30day mortality finding underline importance intervention orthogeriatric care lower 30day mortality risk patients",
        "mesh_terms": [
            "Humans",
            "Male",
            "Denmark",
            "Female",
            "Hip Fractures",
            "Aged",
            "Registries",
            "Comorbidity",
            "Aged, 80 and over",
            "Risk Factors",
            "Chronic Disease",
            "Sex Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788539/",
        "source_type": "Global"
    },
    {
        "pmid": "40788064",
        "title": "Personalized Medication for Chronic Diseases Using Multimodal Data-Driven Chain-of-Decisions.",
        "abstract": "precise matching medication regimen individual patients known personalized medication critical effective management chronic diseases Traditional machine learningbased model personalized medication regimen typically rely solely either clinical macrophenotypes molecularlevel drug characteristics remains challenging capture patientmedication relationship comprehensive perspective integrates individual patient characteristic macro microlevel property medication Determining patientmedication relationship constitutes threestage sequential decision process clinical decisionmaking perspective Therefore inspired ChainofThought prompting simulates decisionmaking process human experts Multimodal DataDriven ChainofDecisions MDDCoD framework proposed threestage deep learning task sequentially organized reflect upstreamdownstream logical dependencies thereby forming coherent clinical decisionmaking process model incorporates multimodal clinical phenotype data multiattribute medication data insight clinical experts Performance evaluation model involved comprehensive experiment utilizing five datasets covering four chronic disease sourced three hospitals dataset comprises information chronic kidney disease CKD membranous nephropathy MN rheumatoid arthritis RA colorectal cancer CRC knee osteoarthritis KOA totaling 3173 unimodal 502 multimodal 2187 medication record 3675 patients Experimental result demonstrate framework achieves enhanced predictive performance personalized medication decisionmaking based individual patient disease characteristics surpassing strongest baseline across tasks framework serf foundational model clinical mixed data improved generalization interpretability crossdisease personalized decisionmaking tasks offer scalable solution implementation personalized medication regimen chronic diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788064/",
        "source_type": "Global"
    },
    {
        "pmid": "40786778",
        "title": "Bilateral Total Hip Arthroplasties Secondary to Renal Osteodystrophy in a Patient with a Rare Cromer Antibody: A Case Report.",
        "abstract": "Bilateral displaced femoral neck fracture uncommon adult without significant trauma especially absence highenergy impact case highlight importance considering underlying metabolic disorder endstage renal disease ESRD significant contributing factors one reported case demonstrating interplay ESRD renal osteodystrophy anemia chronic disease presence rare Cromer blood group antibodies adding unique dimension orthopedic hematological literature present case 50yearold African American female history ESRD dialysis presented bilateral hip pain minor fall Imaging revealed bilateral displaced femoral neck fractures Laboratory workup showed hemoglobin level 74 gdL microcytic anemia Due chronic kidney disease diagnosed renal osteodystrophy contributing bone fragility rare Cromer blood group antibody also detected complicating transfusion planning underwent surgical repair hips postoperative management involved coordinated multidisciplinary care addressing orthopedic hematologic nephrologic concerns case underscore need clinician consider renal osteodystrophy patient ESRD potential cause spontaneous lowimpact fractures addition highlight transfusion challenge posed rare blood group antibody like Cromer system case demonstrates value early recognition prompt surgical intervention interprofessional collaboration managing complex comorbid conditions contributes broader clinical understanding linking metabolic bone disease chronic anemia immunohematologic complication fracture management research personalized treatment protocol rare blood antigen matching could enhance outcome medically complex patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786778/",
        "source_type": "Global"
    },
    {
        "pmid": "40786540",
        "title": "Rethinking Glycemic Thresholds: Diabetic Kidney Disease in the Absence of Overt Diabetes.",
        "abstract": "Diabetic kidney disease traditionally regarded complication chronic hyperglycaemia associated diabetes However relationship glycaemic threshold development diabetic kidney disease increasingly questioned present case 69yearold woman progressive renal dysfunction biopsy finding suggestive diabetic kidney disease despite repeatedly normal glycosylated haemoglobin haemoglobin A1c without clinical diagnosis diabetes prediabetes case highlight limitation current haemoglobin A1c threshold raise question whether diabetic kidney disease truly develop absence diabetes Stricter glycaemic criterion may help identify atrisk patient earlier prevent renal complications Diabetic kidney disease occur without overt diabetes prediabetes challenging current diagnostic methodsReliance haemoglobin A1c alone may miss atrisk individuals stricter glycaemic threshold may warrantedThe diagnosis diabetic kidney disease normoglycemic patient challenge disease definition pathogenesis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786540/",
        "source_type": "Global"
    },
    {
        "pmid": "40786396",
        "title": "Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Frequently Overlooked and Underdiagnosed Condition.",
        "abstract": "Bradycardia renal failure atrioventricular nodal blockade shock hyperkalemia BRASH syndrome defined simultaneous presence five hallmark features Despite potentially severe clinical implications frequently underdiagnosed due symptom overlap conditions Increased awareness understanding syndrome essential prompt diagnosis effective management key preventing serious morbidity 65yearold male medical history cirrhosis portal hypertension heart failure reduced ejection fraction chronic kidney disease ventricular bigeminy presented dizziness low blood pressure started six seven day prior initial examination found bradycardic heart rate 30s laboratory finding revealed hyperkalemia 66 mEqL acute kidney injury creatinine 29 mgdL patient stable dose metoprolol AV nodal blocking agent recently reduced clinic due worsening renal function BRASH syndrome suspected ED prompting initiation treatment epinephrine drip insulin address hyperkalemia Upon admission ICU cardiac catheterization revealed nonobstructive coronary artery disease patients condition improved five days normalization potassium levels restoration normal sinus rhythm resolution kidney injury ultimately leading recovery discharge metoprolol discontinued close cardiology followup arranged Recognizing BRASH syndrome multifaceted clinical entity critical Early identification comprehensive approach managing interdependent component  bradycardia renal failure hyperkalemia  essential halt syndromes progression improve patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786396/",
        "source_type": "Global"
    },
    {
        "pmid": "40786373",
        "title": "Pharmacology and Therapeutic Potential of Finerenone: A Novel Third-Generation Nonsteroidal Mineralocorticoid Receptor Antagonist.",
        "abstract": "Finerenone novel thirdgeneration nonsteroidal mineralocorticoid receptor antagonist MRA demonstrated efficacy treating chronic kidney disease CKD heart failure reduced ejection fraction HFrEF Unlike traditional steroidal MRAs Spironolactone Eplerenone Finerenone offer high selectivity MR resulting reduced offtarget effects including hyperkalemia antiandrogenic side effects exerts renoprotective cardioprotective effect antiinflammatory antifibrotic actions making good therapeutic option patient CKD HFrEF pharmacokinetic profile Finerenone demonstrates rapid absorption satisfactory oral bioavailability predictable systemic clearance contributing efficacy tolerability Clinical trials including advanced Phase III studies established Finerenones ability delay CKD progression reduce proteinuria improve cardiovascular CV outcome such hospitalization heart failure CV death patient diabetes mellitus CKD Compared MRAs Finerenone demonstrates improved tolerability however clinically significant risk hyperkalemia necessitate proactive monitoring protocoldriven management Additionally unique molecular structure mechanism action make safer alternative longterm use diverse populations initial result promising research necessary evaluate longterm outcome explore full therapeutic potential including novel application highrisk patient biomarkerdriven treatments finding position finerenone valuable addition current therapy CKD HFrEF though broader adoption awaits realworld validation safety costeffectiveness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786373/",
        "source_type": "Global"
    },
    {
        "pmid": "40785929",
        "title": "Prospective evaluation of arterial spin labeling and diffusion tensor imaging-magnetic resonance imaging for the non-invasive assessment of renal allograft dysfunction.",
        "abstract": "optimal management strategy endstage renal disease renal transplantation graft function must monitored regularly postoperatively crosssectional study aimed explore value combining functional magnetic resonance imaging MRI parameter laboratory parameter assessing chronic allograft dysfunction CAD compare whether combined approach superior singleparameter indicators total 86 subject enrolled study whom 20 stable renal function 66 biopsyconfirmed CAD Imaging performed 15T MRI system using T2weighted imaging arterial spin labeling ASL diffusion tensor imaging DTI serum creatinine estimated glomerular filtration rate eGFR 24hour urinary protein 24hUP renal blood flow RBF fractional anisotropy FA value subject measured Correlation analysis applied assess MRI parameters association eGFR receiver operating characteristic ROC curve used evaluate diagnostic efficacy fMRI parameter clinical parameter CAD subject categorized CAD group based eGFR levels control group higher renal RBF 27769±6717 ivsi 13860 995419351 FA value cortex 016 014016 ivsi 013 011016 medulla 032±006 ivsi 024 020029 CAD group P001 Cortical RBF decreased progressively across CAD subgroup group 1 mild 21333±6707  group 2 moderate 15114±5321  group 3 severe 9289±3562 P005 Similarly gradual decrease medullary FA across CAD subgroup group 1 029±004 group 2 024 019029 group 3 020±006 However statistically significant difference found medullary FA group 2 3 P0102 correlation analysis showed cortical RBF medullary FA positively correlated eGFR CAD group r0604 P0001 r0574 P0001 combined RBF medullary FA 24hUP eGFR model RBFFA24hUPeGFR area curve AUC 095 95 confidence interval CI 091100 significantly better AUCs single indicator 24hUP medullary FA AUC 078 95 CI 068088 AUC 079 95 CI 069089 P005 Further combined RBF medullary FA and 24hUP model RBFFA24hUP significantly superior single 24hUP differentiating among subgroup all P005 CAD subgroups performance RBF close RBFFA24hUP model AUC combined model showed increasing trend compared RBF Notably RBFFA24hUP model AUC 086 95 CI 076097 P0001 also surpassed medullary FA alone AUC 069 95 CI 054085 P0023 distinguishing subject group 2 group 3 P005 study two multiparametric MRI model RBFFA24hUPeGFR RBFFA24hUP developed shown superior noninvasive CAD assessment tools model outperformed conventional singleparameter method diagnosis moderatetosevere subgroup stratification certain extent model could prevent unnecessary puncture biopsies reduce occurrence complication bleeding infection RBF particular FA showed utility noninvasive biomarkers CAD risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785929/",
        "source_type": "Global"
    },
    {
        "pmid": "40785747",
        "title": "Safe and effective antireflux surgery in lung transplant recipients: preliminary results.",
        "abstract": "Obliterative bronchiolitis clinical manifestation bronchiolitis obliterans syndrome BOS major complication lung transplantation one primary cause chronic lung allograft dysfunction leading poor survival outcomes aim study evaluate safety outcome antireflux surgery lung transplant recipient LTRs BOS associated gastroesophageal reflux disease GERD singlecenter study included 8 consecutive patient median interquartile range IQR age 29 2546 year underwent bilateral lung transplantation subsequent antireflux surgery due BOS decision proceed laparoscopic surgery based diagnosis GERD associated decline pulmonary function confirmed bronchoscopy indicative BOS Followup lasted 12 months Median IQR time since transplantation 27 15555 months Significant improvement spirometric parameter observed 3 12 month postoperatively compared baseline including forced expiratory volume 1 second FEVsub1sub iPi  002 FEVsub1sub predicted iPi  002 forced vital capacity FVC iPi  0003 FVC predicted iPi  002 difference spirometric parameter 3 12 month postoperatively surgical complication observed within 30 day surgery followup Two patient developed pulmonary complications 1 patient history kidney transplantation experienced renal complications postoperative deaths Median IQR hospital stay 12 329 days study suggests antireflux surgery LTRs safe effective approach GERD management improving lung function minimal adverse effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785747/",
        "source_type": "Global"
    },
    {
        "pmid": "40784581",
        "title": "EVOLUTION OF VESICOURETERAL REFLUX IN PATIENTS WITH MYELOMENINGOCELE IN A PROACTIVE FOLLOW-UP PROTOCOL.",
        "abstract": "first six month life patient myelomeningocele MMC incidence vesicoureteral reflux VUR 17 263 proactive treatment approach associated VUR resolution rate 30 50 within 23 years aim assess incidence VUR pediatric patient MMC identify variable involved occurrence analyzed evolution VUR chronic kidney disease CKD using proactive approach compared outcome MMC patient without VUR retrospective observational study included newborn MMC managed proactively 2015 2020 institution Patients grouped based presence absence VUR first videourodynamic study VUDS Demographic characteristic nephronurological variable compared first last year followup 68 patient analyzed 14 VUR first VUDS mean age 6 month R 215 Lowgrade VUR observed 11 786 highgrade VUR three patients resolution rate VUR 643 within 22 month R 749 Surgical closure defect beyond first 24 hour life associated VUR p  0001 57 developed CKD incidence VUR pediatric patient MMC 16 proactive protocol implemented resolution rate VUR 65 within 2 years patient progress CKD Observational cohort study LEVEL EVIDENCE III",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784581/",
        "source_type": "Global"
    },
    {
        "pmid": "40783939",
        "title": "Uncovering the mechanistic basis of <i>Rheum palmatum</i> L. (rhubarb) in the treatment of chronic kidney disease: an integrative approach using network pharmacology, molecular docking, and experimental validation.",
        "abstract": "iRheum palmatumi L Rhubarb shown potential managing Chronic Kidney Disease CKD protective mechanism remain unclear study investigates rhubarbs therapeutic effect underlying mechanism CKD Highperformance liquid chromatography HPLC established rhubarb fingerprint ensure quality control Network pharmacology Mendelian randomization identified primary CKD therapeutic targets Inflammation oxidative stress renal performance assessed ELISAs biochemical tests Renal structure fibrosis examined using hematoxylineosin Masson staining Protein expression related fibrosis apoptosis NFκB pathway activity measured iviai Western blotting Discovery Studio 2019 DS 2019 used molecular docking HPLC fingerprinting confirmed high batchtobatch consistency rhubarb identifying five key anthraquinones aloeemodin rhein emodin chrysophanol physcion similarity index 091 Network pharmacology identified 19 active compound targeting 2597 CKDrelated proteins 47 overlapping target including IL6 TNF TP53 CASP3 IL1B core nodes MR analysis demonstrated statistically significant causal association TNF CKD OR  102 ipi  005 positive trend IL6 CASP3 CKD rat models rhubarb significantly improved renal function reducing blood urea nitrogen BUN serum creatinine SCr uric acid UA level ipi  005 Histopathology showed reduced glomerulosclerosis tubular atrophy interstitial fibrosis inflammatory infiltration treatment Rhubarb markedly decreased renal fibrosis marker including collagen I collagen III αSMA TGFβ ipi  001 Proinflammatory cytokine IL6 IL1β TNFα level significantly suppressed ipi  0001 Antioxidant enzyme activity superoxide dismutase SOD glutathione peroxidase GSHPx restored lipid peroxidation LPO reduced ipi  005 Rhubarb inhibited NFκB pathway activation lowering phosphorylated NFκB IκBα increasing total IκBα expression ipi  001 Apoptosisrelated protein showed upregulated Bcl2 downregulated Bax cleaved caspase3 expression ipi  005 Molecular docking confirmed strong binding affinity rhubarbs core compound key target TNF IL6 supporting therapeutic roles Rhubarb significantly reduces renal impairment fibrosis inflammation apoptosis NFκB pathway supporting traditional use potential adjunct therapy CKD",
        "mesh_terms": [
            "Rheum",
            "Animals",
            "Molecular Docking Simulation",
            "Network Pharmacology",
            "Renal Insufficiency, Chronic",
            "Male",
            "Rats",
            "Rats, Sprague-Dawley",
            "Plant Extracts",
            "Chromatography, High Pressure Liquid",
            "Oxidative Stress",
            "Anthraquinones",
            "Kidney",
            "Apoptosis",
            "Disease Models, Animal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783939/",
        "source_type": "Global"
    },
    {
        "pmid": "40783902",
        "title": "Recurrent pathological fractures in chronic kidney disease revealing overlapping neglected primary hyperparathyroidism and GDF5-associated skeletal dysplasia.",
        "abstract": "Primary hyperparathyroidism PHPT common endocrine disorder characterized excessive secretion parathyroid hormone PTH resulting significant hypercalcemia skeletal complications context chronic kidney disease CKD neglected PHPT progress biochemical profile resembling tertiary hyperparathyroidism THPT complicating diagnosis especially concomitant genetic skeletal disorder GSD exist present rare complex case 63yearold woman stage 3 CKD presented recurrent pathological fractures severe hypercalcemia extensive osteolytic bone lesion femurs patients clinical picture complicated notable skeletal anomalies including short stature brachydactyly hypoplastic metatarsals Elevated serum calcium markedly increased PTH levels hypercalciuria hyperphosphaturia parathyroid imaging confirmed previously untreated PHPT resulting THPTlike biochemical profile setting CKD patient ultimately underwent surgical fixation bilateral lower limb fractures followed simple parathyroidectomy achieving symptomatic relief metabolic stabilization genetic investigation prompted distinctive skeletal features uncovered frameshift mutation growth differentiation factor 5 GDF5 gene indicative brachydactyly type C rare form GSD case highlight complexity differentiating PHPT cause hyperparathyroidism setting CKD particularly concurrent skeletal dysplasia present thorough clinical biochemical imaging genetic assessment pivotal reaching accurate diagnosis guiding appropriate surgical management",
        "mesh_terms": [
            "Humans",
            "Female",
            "Middle Aged",
            "Hyperparathyroidism, Primary",
            "Renal Insufficiency, Chronic",
            "Fractures, Spontaneous",
            "Brachydactyly",
            "Frameshift Mutation",
            "Parathyroidectomy",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783902/",
        "source_type": "Global"
    },
    {
        "pmid": "40783836",
        "title": "[Application of animal drugs in uro-andrological diseases under the guidance of diversified theories of traditional Chinese medicine].",
        "abstract": "Animal drug used treatment uroandrological disease since ancient times present clinical use animal drug mostly based experience doctors perspective diversified theory traditional Chinese medicine TCM paper summarizes experience predecessor use animal drugs belief guidance TCM theories application animal drug treatment uroandrological disease achieved multidimensional diversified development treatment chronic prostatitis based theory heat poison stasis poison aromatherapy orifice management ED perspective kidney deficiency qiblood disharmony collateral disease accord mainstream thought current scholar differentiation treatment uroandrological diseases time pointed problem attended clinical use animal drugs aiming provide reference idea clinical treatment uroandrological disease animal drugs",
        "mesh_terms": [
            "Medicine, Chinese Traditional",
            "Humans",
            "Animals",
            "Urologic Diseases",
            "Drugs, Chinese Herbal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783836/",
        "source_type": "Global"
    },
    {
        "pmid": "40783717",
        "title": "Gender-based distribution of depression and anxiety following acute coronary syndrome in the Turkish population: are women at higher risk?",
        "abstract": "Depression anxiety common psychological disorder following acute coronary syndrome ACS potentially affecting patient outcomes Sexbased disparity prevalence disorder may significantly impact recovery rehabilitation postACS evaluate genderbased difference depression anxiety prevalence among Turkish patient following ACS identify sociodemographic clinical factor associated psychological distress crosssectional observational study 604 patient 144 woman 460 men diagnosed ACS enrolled initial outpatient followup 48 week postdischarge Data collection included demographic clinical survey along Hospital Anxiety Depression Scale HADS Depression anxiety significantly prevalent woman men 611 vs 374 depression p  0001 306 vs 200 anxiety p  0008 Moderatetosevere symptom also common among woman condition p  0001 Lower education level income expense associated higher anxiety depression score p  0025 Among women married individual reported higher anxiety widoweddivorced woman p  0001 Hypertension significantly increased distress particularly men p  0001 chronic kidney disease stronger impact among woman p  0018 marked gender disparity depression anxiety prevalence postACS woman significantly affected Socioeconomic disadvantage comorbid condition contribute psychological distress Routine psychological screening sexsensitive interventions especially vulnerable groups crucial improving outcome ACS Significant gender disparity exist postACS depression anxiety woman disproportionately affected Socioeconomic disadvantage comorbidities compound psychological distress Integrating routine mental health screening sexsensitive intervention postACS care essential particularly highrisk populations improve longterm outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Turkey",
            "Acute Coronary Syndrome",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Depression",
            "Prevalence",
            "Anxiety",
            "Risk Factors",
            "Sex Factors",
            "Aged",
            "Health Status Disparities",
            "Risk Assessment",
            "Sex Distribution",
            "Adult",
            "Psychological Distress",
            "Socioeconomic Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783717/",
        "source_type": "Global"
    },
    {
        "pmid": "40783307",
        "title": "Clinical Frailty Scale and Charlson Comorbidity Index as predictors of hospitalization and mortality risk after kidney transplant failure.",
        "abstract": "Kidney transplant KT recipient experience graft failure return dialysis face higher risk adverse outcomes study aimed identify risk factor hospitalization mortality two year postgraft failure conducted retrospective cohort study endstage kidney disease patient initiated hemodialysis following graft failure January 2019 December 2020 Clinical Frailty Scale CFS Charlson Comorbidity Index CCI assessed patient time graft loss primary outcome hospitalization allcause mortality twoyear followup period total 107 patient included mean age 559 year mean graft survival 134 months twoyear hospitalization rate 374 lower residual diuresis higher CFS identified independent risk factors twoyear mortality rate 168 multivariate regression model explaining 82 variance confirmed higher CCI higher CFS lower residual diuresis significantly increased mortality risk CCI cutoff ≥8 AUC 095 stratified patient elevated mortality risk Immunological transplantrelated variable influence mortality hospitalization risk cohort frailty defined CFS associated hospitalization mortality comorbidity burden evaluated CCI strongly related mortality tool may help personalize care patient failing graft",
        "mesh_terms": [
            "Humans",
            "Kidney Transplantation",
            "Male",
            "Female",
            "Middle Aged",
            "Retrospective Studies",
            "Hospitalization",
            "Frailty",
            "Kidney Failure, Chronic",
            "Risk Factors",
            "Aged",
            "Adult",
            "Postoperative Complications",
            "Renal Dialysis",
            "Treatment Failure",
            "Comorbidity",
            "Risk Assessment"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783307/",
        "source_type": "Global"
    },
    {
        "pmid": "40783306",
        "title": "Particularities of peritoneal dialysis in diabetic patients.",
        "abstract": "Diabetes major cause chronic kidney disease worldwide Managing CKD diabetic patient complex due accumulation comorbid condition hypertension cerebrovascular peripheral artery disease well increased risk infection malnutrition Reaching endstage kidney disease many diabetic patient choose peritoneal dialysis review explores epidemiology outcomes specific management challenge diabetic patient undergoing peritoneal dialysis Literature PubMed MEDLINE 2000 2023 methodically reviewed patient population increased cardiovascular risk unique metabolic challenges need individualized treatment strategy order improve clinical outcome underscored",
        "mesh_terms": [
            "Humans",
            "Peritoneal Dialysis",
            "Diabetic Nephropathies",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783306/",
        "source_type": "Global"
    },
    {
        "pmid": "40782275",
        "title": "Renal Function in Patients after Metabolic and Bariatric Surgery.",
        "abstract": "Obesity risk factor chronic kidney disease CKD also accelerates progression Metabolic bariatric surgery shown improve course CKD significantly study aim explore impact metabolic bariatric surgery renal function various angles including pre postoperative comparisons difference surgical techniques subgroup analysis based kidney function analyzed outcome patient underwent RouxenY gastric bypass RYGB laparoscopic Sleeve Gastrectomy LSG January 2020 May 2023 prospectively managed database hospital Patients grouped based baseline glomerular filtration rate GFR hyperfiltration GFR  125 mLmin normal GFR 12590 mLmin CKD stage 2 GFR 8960 mLmin CKD stage 3 GFR 5930 mLmin Pre postoperative outcome compared subgroup analysis conducted total 278 patient included study 741 undergoing LSG cohort 597 female average BMI 383 ± 847 kgmsup2sup mean age 329 ± 954 years Postoperative GFR slightly increased 115 ± 148 mLmin presurgery 118 ± 154 mLmin postsurgery Significant improvement weight blood glucose lipid levels blood pressure also observed RYGB LSG group showed significant improvement renal function postoperatively GFR decreasing 115 ± 188 mLmin 112 ± 166 mLmin RYGB group 119 ± 139 mLmin 115 ± 188 mLmin LSG group However significant difference two group renal function improvement P  005 subgroup analyses hyperfiltration present 291 patient CKD 5 hyperfiltration group GFR decreased 134 ± 549 mLmin 127 ± 846 mLmin 407 patient returning normal GFR levels However 87 patient normal group developed hyperfiltration 49 showed sign renal impairment Among patient CKD stage 2 3 renal function improved 50 cases Linear regression analysis showed age hypertension status serum urea level significantly associated postoperative GFR level P  05 Metabolic bariatric surgery positively impact renal function one year postoperatively Preoperative attention age hypertension status serum urea level may positively influence patient outcomes addition potential postoperative renal insufficiency considered regular followup assessment essential Early identification treatment abnormality crucial optimizing outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782275/",
        "source_type": "Global"
    },
    {
        "pmid": "40781938",
        "title": "Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.",
        "abstract": "Longterm nucleostide analog NUC therapy essential chronic hepatitis B CHB management However data longterm outcomes particularly patient switching tenofovir alafenamide TAF patient chronic kidney disease CKD remain limited study aimed evaluate 5year virological effectiveness renal safety sequential TAF therapy focus preexisting CKD realworld multicenter retrospective study included 414 CHB patient aged ≥ 18 year switched prior NUC TAF followed least 5 years Patients stratified based renal function CKD nonCKD baseline Study endpoint included 5year virological efficacy biochemical fibrosis responses renal function changes Among patients 100 242 CKD time switching TAF 5 years HBV DNA suppression rate increased 850 100 HBV DNA suppression target detected rate rose 740 910 alanine aminotransferase normalization rate AASLD criteria improved 660 790 similar result patient nonCKD Estimated glomerular filtration rate remained stable regardless baseline renal status prior NUC regimen demonstrating longterm renal safety case HBV DNA breakthrough including among previously combination NUCs patient cirrhosis FIB4 index significantly improved time p  0008 Sequential TAF therapy demonstrated robust virological efficacy biochemical fibrosis improvements excellent renal safety 5 years irrespective baseline renal function",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781938/",
        "source_type": "Global"
    },
    {
        "pmid": "40781195",
        "title": "Femoral artery calcification predicts hip fracture in maintenance hemodialysis patients.",
        "abstract": "Femoral artery calcification FAC significant predictor hip fracture hemodialysis patients higher FAC score associated increased fracture risk poor survival outcomes Identifying FAC radiographic assessment may improve fracture risk stratification clinical management highrisk population Patients endstage renal disease ESRD hemodialysis HD increased risk vascular calcification VC bone fractures previous study linked aortic calcification hip fractures relationship mediumcaliber arteryfemoral artery calcification FAC fallrelated hip fracture HD patient remains unclear retrospectively analyzed 170 HD patient experienced fall sought treatment emergency department ED 2007 2014 FAC score representing severity femoral artery calcification calculated ratio total length calcification plaque length femoral vessel visible plain radiograph hip femur logistic regression model assessed association FAC score hip fracture risk receiver operating characteristic curve analysis evaluated predictive power Among 130 patient meeting inclusion criteria 55 fallrelated hip fractures incidence rate hip fracture among dialysis patient 618 case per 1000 personyears dividing total number hip fracture event cumulative dialysis duration in years enrolled patients Fracture patient older lower serum creatinine sodium albumin level higher aspartate aminotransferase levels fracture group also higher FAC score 047 IQR 028  076 vs 000 IQR 000  040 p  0001 Multivariable analysis identified old age heart failure reduced ejection fraction EF higher FAC score independent risk factor hip fractures Survival curve showed increased mortality among patient higher FAC score hip fracture p  001 High FAC score associated increased risk hip fracture HD patients independent traditional risk factors linked poor survival outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Renal Dialysis",
            "Hip Fractures",
            "Retrospective Studies",
            "Aged",
            "Vascular Calcification",
            "Kidney Failure, Chronic",
            "Middle Aged",
            "Femoral Artery",
            "Accidental Falls",
            "Risk Factors",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781195/",
        "source_type": "Global"
    },
    {
        "pmid": "40779654",
        "title": "Active Surveillance of Biopsy-Confirmed Oncocytic Renal Tumors: Growth Dynamics and Impact on Renal Function.",
        "abstract": "Oncocytic neoplasm account 15 small renal masses Active surveillance AS increasingly adopted lesions however knowledge gap remain regarding growth kinetics concordance renal tumor biopsy impact renal function study review factor largest cohort biopsyconfirmed oncocytic neoplasm managed AS singlecenter retrospective study included patient biopsyconfirmed oncocytoma chromophobe renal cell carcinoma chRCC 20032021 Tumor growth rate change renal function eGFR analyzed using linear mixed models development chronic kidney disease assessed using Cox proportional hazard model Biopsytosurgical pathology concordance trigger intervention examined Among 229 patient 245 lesions 222 oncocytomas 23 chRCC median time first last imaging 47 25 years respectively Predicted growth rate 021 cmyear oncocytoma 031 cmyear chRCC Larger baseline tumor size correlated faster growth p004 age inversely correlated growth rate p001 Intervention common chRCC cohort 35 vs 13 Biopsytosurgical pathology concordance rate 80 oncocytoma 86 chRCC significant association found tumor size renal function decline p03 level p06 event metastasis kidney cancerrelated death median followup 57 year IQR 30 87 Oncocytic lesion demonstrate slow growth low intervention rate preservation renal function excellent diseasespecific survival biopsy limitation exist histologyguided provides effective management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779654/",
        "source_type": "Global"
    },
    {
        "pmid": "40779332",
        "title": "A Qualitative Study to Investigate the Nutrition Perspectives and Experiences of Veterans with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD affect susceptible population higher rate general public Dietary adherence quality behavior play crucial role CKD chronic disease management However individual CKD including Veterans missiondriven occupation cultures face unique challenge navigating dietary recommendation kidneyhealth promoting diets Understanding factor military occupational experiences comorbidities dietary barriers may lead developing effective patientcentered dietary interventions conducted qualitative descriptive study semistructured interview 32 Veterans CKD stages 3b5 including dialysis mean age 71 years 54 WhiteCaucasian 16 women receiving care Veterans Affairs VA Eastern Colorado Health Care System June 2023 July 2024 Interview construct included healthy eating CKD management food preference decision making conducted thematic analysis using inductive approach understand participants perspective experiences Three overarching domain emerged 1 Moments Matter shaping dietary behavior theme health crises diagnoses perceived mortal consequence food choices 2 Chronic Disease Perceptions Management Adaptation capturing burden rigid dietary restrictions conflicting recommendations dichotomy strict rule versus flexible healthy diet principles 3 Contextual Factors Influence Health Nutrition Adaptation highlighting impact social support military culture environmental influence food behaviors Veterans experience CKD nutrition management shaped pivotal health events rigid dietary frameworks militaryinfluenced eating habits socialemotional contextual factors Nutrition healthcare approach focus personalized flexible approach leveraging existing VAbased principle emphasize patientcentered care experience include supporting individual acknowledging urgency dietary decisionmaking capitalizing key moment intervention increasing awareness nutritions role health without reinforcing restrictive unsustainable dietary patterns",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779332/",
        "source_type": "Global"
    },
    {
        "pmid": "40778913",
        "title": "[Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry].",
        "abstract": "Cardiovascular disease CVD chronic obstructive pulmonary disease COPD two leading cause death world Studies show close mutually aggravating relationship arterial hypertension AH COPD Antihypertensive therapy patient AH COPD number features aiming reduce risk developing cardiovascular complication mortality CVD without worsening lung function analyze data patient AH COPD included national registry determine burden CVD risk factors concomitant cardiovascular cerebrovascular disease chronic kidney disease obesity diabetes mellitus gout characteristic antihypertensive therapy comparative analysis patient hypertension registry conducted outpatient clinics performed depending presence ini3323 absence ini54073 chronic obstructive pulmonary disease Statistical analysis obtained data performed using R 433 statistical computing environment R Foundation Statistical Computing Vienna Austria prevalence COPD patient hypertension 58 3323 cases presence COPD patient hypertension regardless gender age statistically significantly associated higher odds coronary artery disease odds ratio OR 221 95 confidence interval CI 206238 ipi0001 history myocardial infarction OR 173 95 CI 159187 ipi0001 chronic heart failure OR 195 95 CI 18221 ipi0001 history acute cerebrovascular accident OR 125 95 CI 107146 ipi0004 transient ischemic attack OR 29 95 CI 231359 ipi0001 atrial fibrillation OR 168 95 CI 145193 ipi0001 Patients hypertension COPD often received drug group angiotensinII receptor antagonist patient hypertension without COPD 227 v 177 prescription drug group betablockers patient hypertension COPD lower 4 Cardiovascular risk factors comorbidities diabetes mellitus gout obstructive sleep apnea patient hypertension COPD common Patients COPD hypertension higher incidence risk factors CVD comorbid pathologies require closer attention examination selection antihypertensive therapy patient hypertension COPD angiotensinconvertingenzyme inhibitor betablockers prescribed less frequently patient hypertension without COPD due possible side effect contraindications",
        "mesh_terms": [
            "Humans",
            "Pulmonary Disease, Chronic Obstructive",
            "Male",
            "Female",
            "Registries",
            "Antihypertensive Agents",
            "Hypertension",
            "Middle Aged",
            "Comorbidity",
            "Aged",
            "Russia",
            "Prevalence",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778913/",
        "source_type": "Global"
    },
    {
        "pmid": "40777989",
        "title": "Renal aging and its consequences: navigating the challenges of an aging population.",
        "abstract": "aggravation population aging kidney aging impact health widely concerned Renal aging involves structural functional change also significantly linked occurrence progression kidney diseases Mechanisms renal aging include oxidative stress reduced Klotho levels cellular senescence chronic inflammation change lead sustained reduction renal filtration reabsorption secretion well endocrine function turn affect overall health Renal structural change mainly include glomerulosclerosis tubular degeneration interstitial fibrosis structural change closely related decline kidney function may lead occurrence chronic kidney disease CKD addition elderly individual experience higher rate acute kidney injury AKI face poorer prospect recovery prevalence agerelated kidney disease especially diabetic nephropathy DN increase age Endstage renal disease ESRD refers advanced stage CKD kidney patient show sign premature aging compared healthy people Measures prevent delay renal aging daily life including healthy lifestyle proper diet adequate exercise also discussed manuscript",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777989/",
        "source_type": "Global"
    },
    {
        "pmid": "40777564",
        "title": "A rare dermatological manifestation of follicular spicules in a patient with multiple myeloma and end-stage renal disease on hemodialysis: A case report.",
        "abstract": "Multiple myeloma MM hematological malignancy characterized clonal expansion malignant plasma cell within bone marrow leading diverse systemic complications cutaneous manifestation MM uncommon follicular spicule represent highly specific rare dermatological finding associated MM present study present case 59yearold man MM exhibited follicular acanthosis hyperkeratosis cutaneous indicator malignancy patient history stage 5 chronic kidney disease undergoing maintenance hemodialysis diagnosed follicular spicule MM FSMM clinical evaluation laboratory investigations present case highlight clinical importance recognizing rare cutaneous manifestation MM serve critical diagnostic clues Improved awareness FSMM may facilitate timely diagnosis optimize patient management ultimately contributing improved clinical outcome challenging population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777564/",
        "source_type": "Global"
    },
    {
        "pmid": "40776944",
        "title": "Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists.",
        "abstract": "Cardiovascular CVkidneymetabolic CKM syndrome complex disorder characterized cooccurrence CV risk factors including chronic kidney disease CKD hypertension metabolic dysfunction creates vicious cycle one factor negatively impact others ultimately leading poor overall CV kidney outcomes Overactivation mineralocorticoid receptor binding aldosterone ligandindependent mechanisms implicated pathogenesis CKM mineralocorticoid receptor antagonist MRAs block interaction Steroidal MRAs currently recommended people heart failure HF reduced ejection fraction hypertension however role nonsteroidal MRAs CKM evolving Indeed steroidal MRAs demonstrated efficacy composite CVrelated mortality hospitalization elevated systolic blood pressure hospitalization worsening HF clinical trial individual HF CKD treatmentresistant hypertension Moreover nonsteroidal MRA finerenone demonstrated risk reduction composite CVrelated outcome CKD progression patient HF mildly reduced preserved ejection fraction people CKD associated type 2 diabetes Ongoing phase 3 trial evaluating efficacy safety nonsteroidal MRAs individual HF reduced ejection fraction well mildly reduced preserved ejection fraction potentially expanding role managing CKM conditions review examines current clinical evidence use MRAs people CKM syndrome",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776944/",
        "source_type": "Global"
    },
    {
        "pmid": "40776292",
        "title": "A Personalized Chatbot to Support Kidney Disease Patients in Saudi Arabia: A Preliminary Study.",
        "abstract": "Chronic kidney disease CKD significant health issue worldwide study investigates potential personalized chatbots support kidney disease patient caregiver Saudi Arabia Using crosssectional design data collected via online questionnaire get insight patient preference willingness use chatbots kidney disease care Findings revealed high acceptance chatbot technology 955 participant willing engage virtual assistant Key feature identified include dietary guidance educational content psychological support study highlight chatbots potential address significant challenge limited knowledge high treatment costs dietary management insight provide foundation developing prototype chatbot tailored need kidney disease patient Saudi Arabia potential enhance healthcare accessibility patient quality life",
        "mesh_terms": [
            "Humans",
            "Saudi Arabia",
            "Cross-Sectional Studies",
            "Female",
            "Male",
            "Middle Aged",
            "Adult",
            "Renal Insufficiency, Chronic",
            "Surveys and Questionnaires",
            "Patient Education as Topic",
            "Patient Preference",
            "Aged",
            "Generative Artificial Intelligence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776292/",
        "source_type": "Global"
    },
    {
        "pmid": "40776040",
        "title": "Personalized Prediction of Chronic Kidney Disease Progression in Patients with Chronic Kidney Disease Stages 3-5: A Multicenter Study Using the Machine Learning Approach.",
        "abstract": "Chronic Kidney Disease CKD prevalent progressive condition lead endstage renal disease ESRD left unmanaged Accurate prediction CKD progression particularly patient CKD stage 35 essential early intervention personalized treatment study utilized machine learning ML model predict decline estimated glomerular filtration rate eGFR one year models including LGBM Random Forest trained large cohort CKD patient Taipei Medical University Clinical Research Database TMUCRD LightGBM emerged topperforming model AUC value 076 082 predicting 5 25 decline eGFR respectively SHAP Shapley Additive Explanations analysis identified baseline eGFR eGFR slope BUN key predictive features result demonstrate utility ML CKD management highlight importance personalized prediction model improving patient outcomes",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Disease Progression",
            "Renal Insufficiency, Chronic",
            "Glomerular Filtration Rate",
            "Female",
            "Male",
            "Precision Medicine",
            "Taiwan",
            "Middle Aged",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776040/",
        "source_type": "Global"
    },
    {
        "pmid": "40775604",
        "title": "Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease.",
        "abstract": "Distal renal tubular acidosis dRTA rare renal disorder caused genetic mutation secondary factors untreated result significant electrolyte imbalance progressive chronic kidney disease CKD study investigated key gene involved renal tubular acidbase regulation iSLC4A1i iATP6V1B1i iATP6V0A4i whole exome sequencing WES clinical cohort Notably patient iATP6V0A4i mutation diagnosed younger age mean 05 years exhibited severe renal impairment including reduced estimated glomerular filtration rate eGFR indicating heightened susceptibility kidney damage identified novel iATP6V0A4i mutation c2219C  T c1971G  C c2293c2296del AGCG confirmed pathogenicity using bioinformatics iin vitroi experiments demonstrated c1971G  C mutation disrupted mRNA splicing causing exon 5 skipping introducing premature termination codon c2293c2296del AGCG introduced premature termination codon c2219C  impaired protein expression intracellular pH regulation ATPase activity Additionally ATP6V0A4 expression decrease diabetes progression contributing tubular dysfunction development diabetic kidney disease DKD finding underscore crucial role ATP6V0A4 maintaining renal acidbase balance influence CKD progression importance genetic analysis early diagnosis personalized management dRTA",
        "mesh_terms": [
            "Humans",
            "Acidosis, Renal Tubular",
            "Vacuolar Proton-Translocating ATPases",
            "Male",
            "Female",
            "Exome Sequencing",
            "Mutation",
            "Glomerular Filtration Rate",
            "Infant",
            "Child, Preschool",
            "Child",
            "Anion Exchange Protein 1, Erythrocyte",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775604/",
        "source_type": "Global"
    },
    {
        "pmid": "40775330",
        "title": "Prevalence and determinants of thirst distress amongst patients on maintenance haemodialysis.",
        "abstract": "Thirst xerostomia main cause poor adherence fluid restriction excessive intake fluid patient chronic haemodialysis Thirst distress defined degree person bothered thirst hence cause high interdialytic weight gain consequence cardiovascular death deterioration quality life hospitalbased crosssectional study carried 18th Dec 2023 11th April 2024 4 governmentfunded haemodialysis centre three randomly selected region Cameroon Patients received twiceweekly dialysis Three hundred patient maintenance haemodialysis 3 month evaluated thirst distress using thirst distress scale characteristics using structured questionnaire dialysis sessions 184 6133 patient thirst distress 123 577 patient Always thirsty 90 patient never consulted thirst distress Two hundred twelve 706 patient felt thirst well managed 194 647 patient felt thirst negative impact comfortable life were Strategies used patient avoid thirst included staying hot sun 256 853 drinking cold iced water 222 739 taking medication meal fluid 222 739 limiting salt food 192 642 xerostomia severity score significantly associated thirst distress p  0001  193 every patient perceived thirst adequately managed significant 389fold decrease TDS score p  0001  3896 Thirst distress negatively impacted quality life patient OR 076 p  0021 61 patient maintenance haemodialysis thirst distress patient never consulted thirst distress determinant thirst distress included xerostomia thirsty frequently well thirst patient felt negative impact comfortable life were applicable",
        "mesh_terms": [
            "Humans",
            "Thirst",
            "Male",
            "Renal Dialysis",
            "Female",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Prevalence",
            "Aged",
            "Xerostomia",
            "Adult",
            "Cameroon",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775330/",
        "source_type": "Global"
    },
    {
        "pmid": "40774919",
        "title": "Complexities in Variant Analysis, Classification, and Interpretation in Kidney Disease-Related Genes.",
        "abstract": "Advancements chronic kidney disease CKD genetic research nextgeneration sequencing improved CKD diagnosis personalized treatment Broad gene panel testing whole exomegenome sequencing greatly improved understanding genetic etiology kidney disease also increased complexity interpretation Standardized variant classification guideline help challenge remain due subjective evidence limited functional phenotypic data Careful consideration genetic clinical evidence along collaboration clinicians genetics experts laboratories essential accurate interpretation patient care article examines nephrology genetic testing focusing complexity variant analysis classification interpretation Variant classification monogenic kidney disease crucial accurate diagnosis patient management outline classification method highlighting several variant example using ACMGAMP framework quantitative approach pathogenicity assessment highlight challenge integrating genetic finding nephrology emphasize clinical impact accurate genetic diagnosis precision medicine CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774919/",
        "source_type": "Global"
    },
    {
        "pmid": "40773437",
        "title": "Interventions to improve cognitive performance in chronic kidney disease: A scoping review.",
        "abstract": "Cognitive impairment commonly associated chronic kidney disease CKD number intervention approach potential improve cognitive performance CKD objective characterize intervention studied improve cognitive performance adult CKD across category severity including kidney failure Scoping review following JBI methodology Adults ≥18 years CKD kidney failure searched 5 electronic database study published April 5 2024 Eligible source primary research study investigated intervention targeting cognition adult ≥18 years CKD kidney failure Fulltext article screening performed duplicate Characteristics interventions population studied outcome investigated Descriptive statistic narrative syntheses Seventyone study included half n  37 52 conducted within past five years study n  47 66 targeted people maintenance hemodialysis therapy onethird study investigated pharmacological interventions much pharmacological medical research focusing anemia management dialysis adequacy Although recent research expanded focus many purported mechanism cognitive dysfunction CKD remain understudied interventional research Exercise training n  14 common nonpharmacological approach studied study explored promising nonpharmacological approach cognitive rehabilitation interventions Abstract screening performed duplicate nonEnglish study excluded Research cognitive intervention people kidney disease primarily focused hemodialysis population investigated erythropoietin stimulating agents frequent prolonged dialysis exercise although recent growth research activity interventions Future research aim address broader range purported pathophysiological mechanism cognitive impairment CKD investigate intervention predialysis peritoneal dialysis patients explore impact established cognitive rehabilitation approaches",
        "mesh_terms": [
            "Humans",
            "Renal Insufficiency, Chronic",
            "Cognition",
            "Cognitive Dysfunction",
            "Renal Dialysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773437/",
        "source_type": "Global"
    },
    {
        "pmid": "40773030",
        "title": "Subaortic membrane in adult patients: retrospective study of clinical characteristics, outcomes, and echocardiographic associations and review of literature.",
        "abstract": "study aim describe clinical characteristics outcomes echocardiographic association subaortic membrane adult patients providing insight multifactorial etiology implication management retrospective study involved identifying patient underwent Transthoracic Echocardiography TTE past 10 year June 2013 June 2023 due clinical suspicion subaortic membrane received confirmed diagnosis subaortic membrane either TTE alone subsequent Transesophageal Echocardiogram TEE demographic patients including age diagnosis sex medical comorbidities aortic mitral valve disease hypertension history arrhythmias coronary artery disease heart failure diabetes mellitus chronic kidney disease included Features TTE documented subsequent surgical intervention recorded specifically subaortic membrane resection valve repair total 22 case studied mean age cohort 581 ± 106 years Common comorbidities included hypertension 636 obesity 454 heart failure 318 Quantitatively left ventricular LV ejection fraction varied normal 59764 moderately decreased 438 mean ejection fraction 659 ± 80 Diastolic dysfunction present various grades Six patient one ICU hospitalization 273 one patient one ICU hospitalization 45 subaortic membrane 909 visualized TTE Two patient possible finding suggestive subaortic membrane confirmed TEE 222 91 patient relatively benign course three patient 136 undergone surgical interventions majority patient survived 1722 773 Subaortic membrane rare condition limited incidence prevalence management data largescale study necessary investigate compile data establish guideline treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773030/",
        "source_type": "Global"
    },
    {
        "pmid": "40771954",
        "title": "Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.",
        "abstract": "10yearold neutered male Ragdoll cat presented symptom anorexia nausea vomiting lethargy progressive weight loss Laboratory parameter clinical sign led diagnosis International Renal Interest Society IRIS Chronic Kidney Disease CKD Stage III Following basic supportive therapy clinical symptom subsided patient discharged home management Three month later cats condition worsened upon reassessment met diagnostic criterion IRIS CKD Stage IV 4 month guidelinedirected supportive care in accordance IRIS recommendations significant change clinical symptom laboratory markers cat continued exhibit cachectic condition Subsequently allogeneic adiposederived mesenchymal stem cell ADMSCs therapy 2 × 10sup6sup cellskg initiated via intravenous IV infusion administered weekly three consecutive weeks adverse events fever vomiting observed therapy Prior ADMSCs therapy cats serum creatinine SCr blood urea nitrogen BUN phosphorus P level normal reference ranges Three week final three ADMSC treatments SCr level returned reference range CKD Stage II BUN P level showed improving trend cats mental status appetite also improved Reevaluation according IRIS CKD staging criterion confirmed functional enhancement Stage IV Stage II subsequent followup period cats physical condition improved shown increase body weight improved Body Condition Score BCS normalization mucous membrane color Concurrently laboratory result revealed decrease key renal biomarkers SCr BUN P amelioration nonregenerative anemia case report suggests allogeneic ADMSCs potential therapeutic efficacy feline endstage CKD offering new possibility treatment terminal chronic kidney disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771954/",
        "source_type": "Global"
    },
    {
        "pmid": "40771508",
        "title": "Nutrition Users' Guides: an introduction to structured guides to evaluate the nutrition literature.",
        "abstract": "Despite evidence nutrition play substantial role curbing burden chronic disease finding reported nutrition literature plagued debate uncertainty including question confidence place evidence observational studies validity dietary intake data applicability randomised trial realworld patient member public Structured nutrition users guide NUGs evaluate common research study design ie randomised trials cohort studies systematic review clinical practice guidelines addressing nutrition question help clinician patients well health service worker policymakers use evidence make informed decision disease management prevention addition NUGs provide comprehensive teaching material nutrition trainee appraise interpret apply research evidence hereby introduce series structured NUGs literature nutrients food dietary pattern programmes article address three key component assessing different study design used assess nutrition intervention exposures including 1 assessing methodological quality study 2 interpreting study result magnitude precision treatment exposure effect outcome benefit harm 3 applying result unique patient population scenario based healthrelated value preference related potential benefits harms convenience cost intervention series article serve empower clinicians health service worker health policymakers better understand validity interpretability applicability nutrition literature also helping practitioner client make evidencebased valuesensitive preferencesensitive nutrition decisions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771508/",
        "source_type": "Global"
    },
    {
        "pmid": "40771113",
        "title": "From Metabolic Syndrome to Cardiovascular-Kidney-Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction.",
        "abstract": "landscape metabolic health evolved dramatically recent years viewed collection distinct conditions disorder like obesity type 2 diabetes cardiovascular disease chronic kidney disease fatty liver disease understood share common pathophysiological roots review explores transition traditional concept metabolic syndrome toward comprehensive clinically relevant frameworks namely cardiovascularkidneymetabolic CKM syndrome proposed American Heart Association systemic metabolic disorder SMD framework introduced European Atherosclerosis Society model recognize progressive multisystemic nature metabolic dysfunction highlight need stagebased risk stratification emphasize early intervention author discus central role dysfunctional adiposity ectopic fat driving organspecific damage examine growing body evidence supporting use novel therapy sodiumglucose cotransporter 2 SGLT2 inhibitors glucagonlike peptide1 receptor agonist GLP1RA gastric inhibitory polypeptide GIPGLP1RA delivering multiorgan protection comparing CKM SMD models author highlight complementary nature shared call shift clinical thinking away isolated management toward integrated multidisciplinary care burden metabolic dysfunction continues rise need recognize obesity chronic disease develop practical collaborative strategy across cardiology nephrology endocrinology hepatology becomes even urgent rise cardiometabolic medicine offer timely necessary response growing challenge creating opportunity better prevention earlier detection improved outcome patients",
        "mesh_terms": [
            "Humans",
            "Metabolic Syndrome",
            "Cardiovascular Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771113/",
        "source_type": "Global"
    },
    {
        "pmid": "40770794",
        "title": "Prognostic value of left atrioventricular coupling index assessed by 3D echocardiography in patients with chronic kidney disease and heart failure with preserved ejection fraction.",
        "abstract": "evaluate prognostic value threedimensional echocardiographyderived left atrioventricular coupling index LACI patient chronic kidney disease CKD concomitant heart failure preserved ejection fraction HFpEF analysis 108 patient CKD combined HFpEF conducted Participants categorized three group based LACI difference clinical echocardiographic characteristic group assessed Independent association LACI clinical outcome assessed using Cox proportional hazard regression modeling addition analysis performed determine predictive performance LACI adverse cardiovascular event calculating area curve AUC optimal threshold median LACI study 025 stratified tertiles patient high LACI group  033 significantly older advanced CKD stages severe left ventricular diastolic dysfunction LVDD all P  005 increasing LACI levels proportion grade 1 LVDD progressively decreased grade 3 LVDD increased 7 21 58 P  0001 LACI ≥ 0235 demonstrated discriminative capability moderatetosevere LVDD AUC  0739 P  0001 Multivariable Cox proportional hazard regression confirmed LACI independent predictor major clinical outcome HR  132 95 CI 07920894 P  0001 optimal cutoff value 026 AUC  0843 P  0001 effectively stratified highrisk patient logrank P  0001 Net reclassification improvement NRI analysis demonstrated incorporating LACI significantly enhanced incremental predictive value traditional clinical models LACI quantified threedimensional echocardiography 3DE correlate severity LVDD LACI independent predictor adverse clinical outcome patient CKD combined HFpEF providing objective quantitative metric guide therapeutic decisionmaking highrisk population",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Heart Failure",
            "Renal Insufficiency, Chronic",
            "Aged",
            "Predictive Value of Tests",
            "Stroke Volume",
            "Echocardiography, Three-Dimensional",
            "Middle Aged",
            "Prognosis",
            "Ventricular Function, Left",
            "Risk Factors",
            "Atrial Function, Left",
            "Retrospective Studies",
            "Ventricular Dysfunction, Left",
            "Risk Assessment",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770794/",
        "source_type": "Global"
    },
    {
        "pmid": "40770708",
        "title": "Whole exome sequencing and polygenic risk assessment for kidney functions and clinical management in both hospital-based cohort and population-based Asian cohorts.",
        "abstract": "Taiwan highest prevalence chronic kidney disease CKD endstage kidney disease ESKD globally making major public health concern significant morbidity mortality healthcare burden genetic risk factor kidney disease identified previous studies contribution rare genetic variant remains unclear study utilized wholeexome sequencing WES investigate role missense rare variant CKD ESKD susceptibility Genomic data 500 Taiwanese individual Taipei Medical University Hospital included based strict clinical diagnostic criteria comprising 200 CKD cases 200 ESKD cases 100 healthy controls Independent validation performed using ESKD Asian cohort Us Research Program AoU N  222 Tohoku Medical Megabank Organization ToMMo N  140 identified rare pathogenic variant known monogenic kidney disease genes including PKD1 COL4A4 confirming role disease susceptibility replicated GWASreported gene SPI1 RIN3 FTO SIPA1L3 EEF1E1 highlighting contribution common rare variants Beyond previously reported genes identified novel rare pathogenic variant PEX1 GANAB DYNC2H1 PROKR2 Pathway enrichment analysis suggested ciliopathies inflammation metabolic dysfunction may contribute kidney disease progression Furthermore polygenic score PGS ESKD demonstrated strong predictive utility kidney function high genetic risk greater influence comorbidities diabetes overweight prediction power ESKD PGS confirmed AoU Asian population study provides novel insight genetic architecture CKD ESKD Taiwanese population utilizing hospitalbased cohort strict clinical diagnostic criterion ensure precise phenotype classification propose individual high genetic risk may benefit earlier interventions lower PGS may better managed lifestyle modification targeting comorbidities finding highlight importance preventive strategy precision medicine kidney disease management",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Exome Sequencing",
            "Middle Aged",
            "Renal Insufficiency, Chronic",
            "Taiwan",
            "Cohort Studies",
            "Multifactorial Inheritance",
            "Kidney Failure, Chronic",
            "Adult",
            "Genetic Predisposition to Disease",
            "Risk Assessment",
            "Asian People",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770708/",
        "source_type": "Global"
    },
    {
        "pmid": "40770657",
        "title": "Glycemic index of some protein-free food products for individuals with non-dialysis-dependent chronic kidney disease.",
        "abstract": "Chronic kidney disease CKD major public health issue third leading cause death globally conservative phase CKD lowprotein diet recommended slow disease progression proteinfree product commonly used clinical nutrition CKD Since diabetes highly prevalent population crucial food also low glycemic index GI support glycemic control reduce associated complications study aimed assess GI selected commercial proteinfree products Twelve healthy volunteer six males six females mean age 207 ± 08 years BMI 226 ± 36 kgm² consumed four commonly available proteinfree foods sliced white bread pasta crackers cooky filled vanilla cream with sweeteners GI product calculated according ISO 2010 standards using glucose reference test meal provided 50 g available carbohydrates GI value ranged 48 cooky filled vanilla cream 69 crackers Sliced white bread GI 494 cooky GI 478 classified lowGI foods pasta GI 682 cracker GI 692 fell within mediumGI range Several commercially available proteinfree product exhibit low moderate GI values supporting use dietary management patient nondialysisdependent CKD risk diabetes However given growing market products studiesincluding patient CKDare needed expand current evidence base",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770657/",
        "source_type": "Global"
    },
    {
        "pmid": "40769320",
        "title": "UV Spectrophotometric analysis of phosphate content in plant-based milk alternatives in relation to Advanced Chronic Kidney Disease.",
        "abstract": "Managing dietary phosphorus critical advanced chronic kidney disease CKD excess intake lead complication hyperphosphataemia Plantbased milk alternative PBMAs increasingly consumed yet phosphorus content particularly relation phosphate additives remains poorly defined UK study aimed quantify compare total phosphorus content phosphorustoprotein ratio PPR range commercially available UK PBMAs without phosphate additives using UV spectrophotometric analysis Fourteen PBMAs from seven plant sources analysed using molybdenum blue method Samples categorised based presence absence phosphate additives Phosphorus content mg100g PPR mgg protein calculated compared previously documented data cows milk PBMAs phosphate additive contained significantly higher phosphorus level mean 5847 mg100g without mean 738 mg100g p  001 Similarly PPR substantially higher additivecontaining PBMAs mean 19776 mgg versus additivefree option mean 1625 mgg p  001 PBMAs additive phosphorus content PPR value exceeding cows milk raising concern phosphate management CKD Phosphate additive significantly increase phosphorus load PPR PBMAs may readily apparent consumer clinician due insufficient labelling patient advanced CKD selecting additivefree PBMAs may support better phosphorus control dietary management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769320/",
        "source_type": "Global"
    },
    {
        "pmid": "40769236",
        "title": "Metabolic syndrome, ischemic heart disease, and heart failure: insights from the Colombian Heart Failure Registry (RECOLFACA).",
        "abstract": "Ischemic heart disease IHD still leading cause morbidity mortality worldwide major implication healthcare systems especially low middleincome countries Effective metabolic control risk factor management including evidencebased pharmacological therapy statins ACE inhibitor ACEIs angiotensin receptorneprilysin inhibitor ARNIs essential reducing adverse outcomes However gap persist implementation therapies particularly resourcelimited regions evaluate metabolic control use evidencebased therapy patient IHD enrolled Colombian Heart Failure Registry RECOLFACA identify barrier optimal treatment implementation crosssectional study analyzed demographic clinical biochemical data well medication usage patient confirmed IHD Descriptive inferential statistical analysis performed identify treatment pattern associated factors Among 2528 patient heart failure HF 1123 IHD Statins prescribed 736 827 antiplatelets 663 745 ARNIs 101 114 despite guideline recommendations Statin use notably low among patient chronic kidney disease CKD 181 diabetes mellitus type 2 158 condition combined 32 Despite robust evidence supporting efficacy use statins ACEIs ARNIs remains suboptimal Colombia Addressing barrier access adherence healthcare delivery crucial improve outcome align clinical practice international standards finding highlight need targeted intervention future study evaluate strategy enhance access adherence guidelinedirected therapies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769236/",
        "source_type": "Global"
    },
    {
        "pmid": "40768492",
        "title": "Limited predictive value of traditional comorbidities for readmission in acute decompensated heart failure.",
        "abstract": "Common comorbidities heart failure HF including chronic kidney disease CKD diabetes mellitus DM ischemic heart disease IHD atrial fibrillation frequently presumed predict hospital readmission However recent study challenged predictive strength raising question clinical utility risk stratification conducted retrospective cohort study 7652 patient admitted acute decompensated heart failure ADHF tertiary center 2007 2017 Associations comorbidities readmission 30 100 day assessed using FineGray competing risk models death competing event Subdistribution hazard ratio sHRs reported Model performance evaluated using receiver operating characteristic ROC analysis area curve AUC values assessing individual comorbidities incremental combinations comorbidities included irrespective univariable significance based clinical relevance Several comorbidities significantly associated readmission including CKD sHR 116123 DM sHR 118127 IHD sHR 110115 anemia sHR 111 However predictive power poor 30day readmission AUC value ranged 0516 COPD 0529 CKD maximal AUC 0555 combining four strongest predictors 100day readmission AUC value ranged 0528 DM 0545 CKD maximal combined AUC 0593 Despite consistent statistical associations common comorbidities perform poorly predictive tool identifying individual patient risk HF readmission finding highlight need robust risk model integrating dynamic clinical laboratory patientcentered factors",
        "mesh_terms": [
            "Humans",
            "Heart Failure",
            "Patient Readmission",
            "Male",
            "Female",
            "Aged",
            "Comorbidity",
            "Retrospective Studies",
            "Middle Aged",
            "Aged, 80 and over",
            "Renal Insufficiency, Chronic",
            "Risk Factors",
            "ROC Curve",
            "Diabetes Mellitus",
            "Risk Assessment",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768492/",
        "source_type": "Global"
    },
    {
        "pmid": "40768478",
        "title": "Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.",
        "abstract": "Breast cancer survivor increased risk colorectal cancer CRC chronic disease likely experience poor mental physical health study examined mediating effect mental physical health association chronic disease condition guidelineconcordant colorectal cancer CRC screening among breast cancer survivors included 1885 breast cancer survivor aged 4575 year eligible CRC screening 2016 2018 2020 Behavioral Risk Factor Surveillance System exposure chronic disease defined prevalent diabetes coronary heart diseasemyocardial infarction stroke chronic obstructive pulmonary disease emphysemachronic bronchitis arthritis depressive disorders kidney diseases outcome receipt guidelineconcordant CRC screening Mediators defined selfreported frequent poor mentalphysical health past 30 day 1430 vs 013 days Multivariable logistic regression model adjusted sociodemographic cancerrelated factors used method proposed Valeri  VanderWeele mediation analyses Breast cancer survivor chronic disease 17fold likely CRC screening compared without chronic disease OR 168 95 CI 127221 mediation analysis found frequent poor mental health mediated association chronic disease condition CRC screening utilization 44 mediated pvalue  0035 also observed reduction frequent poor physical health 105 pvalue  0008 Frequent poor mental physical health negatively mediated association presence chronic disease CRC screening utilization higher estimate poor physical health Effective implementation integrated followup care needed among breast cancer survivor address chronic disease management prioritize mental physical health patient receive guideline concordant CRC screening recommendations",
        "mesh_terms": [
            "Humans",
            "Female",
            "Breast Neoplasms",
            "Colorectal Neoplasms",
            "Middle Aged",
            "Cancer Survivors",
            "Aged",
            "Early Detection of Cancer",
            "Chronic Disease",
            "Mental Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768478/",
        "source_type": "Global"
    },
    {
        "pmid": "40768294",
        "title": "Validation of the Klinrisk Machine Learning Model for CKD Progression in a Large Representative US Population.",
        "abstract": "Early identification highrisk chronic kidney disease CKD facilitate optimal medical management improve outcomes aimed validate Klinrisk machine learning model prediction CKD progression large US commercial Medicare Medicaid populations developed three cohorts consisting insured adult enrolled a commercial b Medicare c Medicaid plan 01012007 12312020 ≥1 serum creatinine test eGFR 15mlmin173m 2 180mlmin173m 2  ≥7 19 laboratory analytes available Two primary subcohorts evaluated within insurer 1 patient ≥7 laboratory analytes 2 patient 1 available urinalysis results Disease progression defined composite outcome sustained 40 decline eGFR kidney failure Discrimination accuracy calibration assessed using area receiver operator characteristic curve AUC Brier scores calibration plots commercial cohort Klinrisk model achieved AUCs ranging 083 95 confidence interval 082  083 087 086  087 maximum Brier score 0005 00005  0005 2 years Medicare patients AUCs ranged 080 079  080 081 080  082 maximum Brier score 0026 0025  0027 Medicaid patients found AUCs ranging 082 082  082 084 082  086 maximum Brier score 0014 0012  0015 Klinrisk machine learning model accurate predicting CKD progression 48 million US adult across commercial Medicare Medicaid populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768294/",
        "source_type": "Global"
    },
    {
        "pmid": "40768026",
        "title": "Effects of NSAIDs on Early CKD Development: A 10-Year Population-Based Study Using the Korean Senior Cohort.",
        "abstract": "Nonsteroidal antiinflammatory drug NSAIDs widely used pain management associated nephrotoxicity particularly senior populations acute nephrotoxicity NSAIDs well established evidence longterm effect renal functionparticularly communitydwelling older adultshas mixed across studies study investigated association NSAID use chronic kidney disease CKD risk general senior population Data National Health Insurance ServiceSenior Cohort NHISSC South Korea analyzed including 1812 participant 604 NSAID user 1208 controls matched 12 propensity score Kidney dysfunction defined glomerular filtration rate eGFR  60 mLmin173msup2sup ≥ 10 decline baseline Hazard ratio HRs CKD estimated using Cox regression NSAID use associated increased CKD risk HR 146 95 confidence interval CI 111193 faster eGFR decline Subgroup analysis showed elevated risk Cox1 HR 153 Cox2 inhibitor HR 161 Endstage renal disease ESRD incidence rare significant NSAIDs increase CKD risk accelerate kidney function decline senior individuals Cautious prescription regular kidney monitoring recommended randomized trial needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768026/",
        "source_type": "Global"
    }
]